{"gene":"KLF2","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":1997,"finding":"LKLF/KLF2 is required to program the quiescent state of single-positive T cells and maintain their viability; LKLF-deficient T cells produced by gene targeting had a spontaneously activated phenotype and died from Fas ligand-induced apoptosis in peripheral lymphoid organs.","method":"Gene targeting (knockout mouse), in vivo phenotypic analysis of T cell activation and apoptosis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with defined cellular phenotype (spontaneous activation, Fas-mediated apoptosis), replicated in same study with multiple readouts","pmids":["9302292"],"is_preprint":false},{"year":1997,"finding":"LKLF/KLF2 expressed in vascular endothelial cells is required for tunica media formation and vessel wall stabilization; LKLF-deficient embryos die from hemorrhage with defects in smooth muscle cell organization, reduced pericytes, and decreased extracellular matrix deposition in vessel walls.","method":"Homologous recombination (knockout mouse), in situ hybridization, immunohistochemistry, electron microscopy","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined vascular morphogenesis phenotype, multiple orthogonal methods in one study","pmids":["9367982"],"is_preprint":false},{"year":1998,"finding":"Loss of LKLF/KLF2 causes embryonic lethality with abdominal bleeding, craniofacial abnormalities, and failure of fetal liver erythroid colony formation in vitro, establishing an essential and non-redundant role in embryonic erythropoiesis that cannot be compensated by the closely related EKLF.","method":"Gene targeting (knockout mouse), in vitro fetal liver erythroid colony assay","journal":"Transgenic research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined phenotype, complementary in vitro functional assay, replicates LKLF vascular KO findings independently","pmids":["9859212"],"is_preprint":false},{"year":2001,"finding":"Forced expression of LKLF/KLF2 in Jurkat T cells is sufficient to program a quiescent phenotype (decreased proliferation, reduced cell size, decreased activation markers) partly by decreasing c-Myc expression; the effects of LKLF are mimicked by dominant-negative MadMyc and rescued by c-Myc overexpression.","method":"Retroviral/plasmid overexpression in Jurkat cells, dominant-negative rescue, gene targeting KO for complementation","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function and epistasis rescue experiments, replicated with KO model, multiple orthogonal readouts","pmids":["11477405"],"is_preprint":false},{"year":2002,"finding":"KLF2 directly inhibits PPARγ2 promoter activity (70% inhibition) by binding a specific site in the PPARγ2 promoter, thereby acting as a negative regulator of adipogenesis by repressing PPARγ as well as downstream factors C/EBPα and SREBP1c; KLF2 had no effect on upstream C/EBPβ or C/EBPδ.","method":"Transient transfection reporter assay, promoter mutational analysis, gel mobility shift assay (EMSA), overexpression in preadipocytes and primary cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter binding demonstrated by EMSA and mutational analysis, functional reporter assay, single lab with multiple orthogonal methods","pmids":["12426306"],"is_preprint":false},{"year":2003,"finding":"TRAF2 regulates LKLF/KLF2 expression through the p38 MAP kinase pathway (not via TNF signaling or NF-κB); ectopic LKLF expression in TRAF2-deficient cells protected against TNF-induced apoptosis, placing LKLF downstream of TRAF2/p38 in an anti-apoptotic pathway.","method":"Microarray gene expression comparison of TRAF2−/− vs. WT cells, ectopic expression rescue, pathway inhibitor analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by rescue experiment and pathway inhibitor, single lab with two orthogonal methods","pmids":["12897154"],"is_preprint":false},{"year":2004,"finding":"KLF2 inhibits proliferation of Jurkat T leukemia cells by upregulating p21WAF1/CIP1 expression; the functional responsive element in the p21 promoter is the Sp1-3 binding site (not the CACCC site), and both activation and inhibitory domains of KLF2 are required for this effect.","method":"Tetracycline-inducible expression system, 3H-thymidine uptake assay, luciferase reporter assay, promoter deletion/mutation analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter binding and transcriptional activation characterized by reporter assay with mutational analysis, multiple cell lines tested","pmids":["15361832"],"is_preprint":false},{"year":2005,"finding":"KLF2 regulates endothelial thrombotic function by transcriptionally inducing thrombomodulin and eNOS, reducing PAI-1, and inhibiting cytokine-induced tissue factor expression; siRNA knockdown of KLF2 reduces antithrombotic gene expression and reduces blood clotting time in functional clotting assays.","method":"Adenoviral overexpression, siRNA knockdown, gene expression analysis, in vitro clotting assays","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional manipulation (overexpression and knockdown) with functional clotting assay readout, multiple target genes validated","pmids":["15718498"],"is_preprint":false},{"year":2005,"finding":"KLF2 (LKLF) is regulated by shear stress in vivo at high-shear arterial sites and acts as a transcriptional regulator of vascular tone genes; KLF2 repression by siRNA suppressed the flow response of endothelin-1, adrenomedullin, and eNOS, establishing KLF2 as a downstream mediator of the shear stress-to-gene expression axis.","method":"Carotid artery collar model (in vivo), siRNA knockdown, in situ hybridization, laser microdissection/RT-PCR, shear stress chamber experiments","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo and in vitro validated, siRNA functional knockdown with defined gene expression phenotype, multiple orthogonal methods","pmids":["16049344"],"is_preprint":false},{"year":2007,"finding":"KLF2 inhibits proinflammatory gene expression in endothelial cells under laminar shear stress by suppressing nuclear binding activity of ATF2; siRNA knockdown of ATF2 suppressed basal proinflammatory gene expression under no-flow conditions, placing KLF2-mediated ATF2 inhibition as the mechanism of atheroprotection.","method":"Genome-wide expression profiling, promoter analysis, ATF2 nuclear binding activity assay, siRNA knockdown, HUVEC shear stress experiments","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple gene expression methods plus nuclear binding assay, single lab, siRNA validation of KLF2-ATF2 link","pmids":["17244683"],"is_preprint":false},{"year":2010,"finding":"B cell-specific KLF2 deficiency leads to decreased expression of trafficking molecules CD62L and β7-integrin, a drastic reduction in the B1 B-cell pool, increased transitional and marginal zone B-cell numbers, increased apoptosis, and impaired proliferation after BCR cross-linking; S1PR1 expression was unexpectedly minimally altered in B cells.","method":"B cell-specific conditional KO mouse, flow cytometry, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific genetic KO with multiple defined phenotypic readouts (subset numbers, apoptosis, proliferation, trafficking molecule expression)","pmids":["21187410"],"is_preprint":false},{"year":2011,"finding":"KLF1 and KLF2 directly bind the promoters of human ε- and γ-globin genes, mouse Ey- and βh1-globin genes, and the β-globin locus control region in embryonic blood cells, positively regulating embryonic and fetal β-globin gene expression; KLF1 loss reduces H3K9Ac and H3K4me3 marks at these loci.","method":"Chromatin immunoprecipitation (ChIP) with embryonic blood cells, conditional KO mouse models, dual transgenic human β-globin locus mouse model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct promoter binding established by ChIP in primary cells, genetic KO complementation, histone modification analysis, multiple loci validated","pmids":["21610079"],"is_preprint":false},{"year":2014,"finding":"KLF2 represses PFKFB3 promoter activity, thereby inhibiting endothelial glycolysis under laminar shear stress; KLF2 overexpression reduces glucose uptake, glycolytic enzyme expression (PFKFB3, PFK-1, HK2), and angiogenic sprouting, effects partially reversed by PFKFB3 overexpression.","method":"Seahorse flux analysis, glucose uptake assays, RNA sequencing, luciferase reporter assay, siRNA/overexpression, endothelial-specific KLF2 KO mouse","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct promoter activity assay, in vitro metabolic flux measurements, in vivo KO validation, epistasis rescue with PFKFB3 overexpression","pmids":["25359860"],"is_preprint":false},{"year":2014,"finding":"In zebrafish, loss of CCM proteins upregulates klf2 mRNA through a β1 integrin-dependent mechanism (independent of blood flow), which causes enhanced egfl7 expression and angiogenic signaling; downregulation of β1 integrin rescues CCM cardiovascular malformations, establishing a β1 integrin-Klf2-Egfl7 pathway regulated by CCM proteins.","method":"Zebrafish CCM morpholino/mutant model, HUVEC siRNA knockdown, in vivo rescue experiments","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in zebrafish with in vitro mechanistic follow-up in human ECs, single lab","pmids":["25625207"],"is_preprint":false},{"year":2014,"finding":"KLF2 mutations in splenic marginal zone lymphoma (predominantly in the C-terminal zinc finger domains) inactivate the ability of KLF2 to suppress NF-κB activation by TLR, BCR, BAFFR, and TNFR signaling, as shown by functional assays.","method":"Whole exome sequencing, functional NF-κB reporter assays with mutant KLF2 constructs","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay validating mechanistic consequence of mutations, single lab","pmids":["25428260"],"is_preprint":false},{"year":2015,"finding":"KLF2 restrains CD4+ T follicular helper (Tfh) cell differentiation through two mechanisms: (1) promoting S1PR1 expression to control T cell localization (S1PR1 downregulation is required for Tfh generation), and (2) inducing Blimp-1 expression which represses Bcl-6, thereby impairing Tfh differentiation; KLF2 also induces T-bet and GATA3 to enhance Th1 differentiation.","method":"Inducible KLF2 deletion in activated CD4+ T cells, KLF2 overexpression, gene expression analysis, in vivo Tfh quantification","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional genetic manipulation (KO and overexpression) with multiple mechanistic readouts (S1PR1, Blimp-1, Bcl-6, T-bet, GATA3), defined cellular phenotype","pmids":["25692701"],"is_preprint":false},{"year":2016,"finding":"CCM disease pathogenesis involves gain of MEKK3-KLF2/4 signaling: loss of CCM complex (KRIT1, CCM2, PDCD10) increases MEKK3 kinase activity which elevates KLF2 and KLF4 expression and Rho activity in endothelial cells of CCM lesions; endothelial-specific loss of Mekk3, Klf2, or Klf4 prevents lesion formation and rescues lethality in a neonatal mouse CCM model.","method":"Neonatal mouse CCM model, endothelial-specific conditional KO of Mekk3/Klf2/Klf4, human CCM lesion immunostaining, CCM2 disease-causing mutation analysis (abrogates MEKK3 interaction)","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent genetic KOs in mouse model, human tissue validation, disease mutation functional characterization, replicated across multiple CCM models","pmids":["27027284"],"is_preprint":false},{"year":2016,"finding":"KDM3A histone demethylase maintains KLF2 expression through H3K9 demethylation at the KLF2 locus; KLF2 directly activates IRF4 transcription, and IRF4 reciprocally upregulates KLF2, forming a positive autoregulatory circuit; KLF2 silencing triggers apoptosis in multiple myeloma cells and decreases ITGB7-dependent cell adhesion to bone marrow stromal cells.","method":"siRNA knockdown (KDM3A, KLF2, IRF4), ChIP for H3K9 methylation, in vitro and in vivo MM models, gene expression analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — histone modification ChIP, multiple siRNA knockdowns with defined apoptosis and adhesion phenotypes, in vivo validation, single lab with multiple orthogonal methods","pmids":["26728187"],"is_preprint":false},{"year":2016,"finding":"KLF2 is a transcription factor required for homeostatic NK cell proliferation and survival; KLF2 deficiency promotes spontaneous proliferation of immature NK cells and regulates a subset of homing receptors that allow mature NK cells to access IL-15-rich microenvironments; KLF2-deficient NK cells undergo apoptosis due to IL-15 starvation.","method":"Gene-targeted KO mouse models, ex vivo NK cell proliferation assays, homing receptor expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined proliferation, survival and homing receptor phenotypes, multiple experimental approaches","pmids":["27114551"],"is_preprint":false},{"year":2017,"finding":"Inducible endothelial-specific deletion of both Klf2 and Klf4 (EC-DKO) causes acute death from myocardial infarction, heart failure, and stroke with profound compromise of vascular integrity and dysregulation of the coagulation system; a single allele of either gene is sufficient for survival, establishing that KLF2 and KLF4 together control a large segment of the endothelial transcriptome essential for vascular integrity.","method":"Inducible endothelial-specific double KO mouse (Klf2/Klf4), transcriptome analysis, coagulation assays","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible cell-type-specific double KO with lethal phenotype and defined molecular/coagulation readouts, gene dosage analysis","pmids":["28239661"],"is_preprint":false},{"year":2017,"finding":"KLF2 inhibits endothelial cell migration by KLF2-dependent transcriptional repression of PAK1 (a pro-migratory Rac/Cdc42 mediator); Erk5 activation (via constitutively active MEK5, statins, or shear stress) decreases PAK1 mRNA and protein through KLF2 but not KLF4; PAK1 re-expression or KLF2 knockdown restores migration in Erk5-activated ECs.","method":"Constitutively active MEK5 expression, siRNA knockdown (KLF2, KLF4), PAK1 re-expression rescue, migration assays, statin/shear stress treatment","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis by rescue experiment (PAK1 re-expression restores migration), KLF2-specific vs. KLF4 discrimination by siRNA, single lab","pmids":["25388666"],"is_preprint":false},{"year":2014,"finding":"IKKβ inhibition increases thrombomodulin (TM) expression and function through a KLF2-dependent mechanism: IKKβ inhibition causes KLF2 overexpression and enhanced KLF2 binding to the TM promoter (demonstrated by ChIP); KLF2 knockdown completely attenuates IKKβ-inhibition-mediated TM upregulation.","method":"IKKβ chemical inhibitors, siRNA/shRNA knockdown, ChIP assay, luciferase reporter assay, flow cytometry, APC generation assay","journal":"Journal of thrombosis and haemostasis","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP, functional rescue by KLF2 knockdown, multiple methods for TM quantification in single lab","pmids":["25039491"],"is_preprint":false},{"year":2015,"finding":"KLF2 directly binds the AQP1 (aquaporin-1) promoter (demonstrated by ChIP) and positively regulates AQP1 expression in endothelial cells; inflammatory stimuli repress AQP1 in an effect restrained by KLF2 overexpression.","method":"Chromatin immunoprecipitation (ChIP), KLF2 overexpression, siRNA, gene expression profiling, immunohistochemistry in human vascular tissue","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP, functional validation by overexpression/siRNA, single lab","pmids":["26717516"],"is_preprint":false},{"year":2015,"finding":"miR-302-367 downregulates Erk1/2, which increases KLF2 expression, which in turn upregulates S1PR1 and VE-cadherin, suppressing angiogenesis and improving vascular stability; this Erk1/2-Klf2-S1pr1 pathway was validated by genetic S1pr1 deletion which reversed the antiangiogenic effects of miR-302-367.","method":"Endothelial-specific miR302-367 overexpression in mice, S1pr1 genetic deletion, retinal angiogenesis assay, tumor angiogenesis models","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo (S1pr1 KO rescue), pathway placement by sequential knockdown, single lab","pmids":["27756792"],"is_preprint":false},{"year":2015,"finding":"Simvastatin activates KLF2 expression through a Rac1-Rab7-autophagy dependent mechanism; KLF2 induction in turn promotes further activation of autophagy, forming a positive feedback loop; this autophagy-KLF2 relationship modulates endothelial phenotype and survival in acute liver injury.","method":"Pharmacological inhibition (GGTI-298, statins, resveratrol), adenoviral KLF2 overexpression, autophagic flux assays, LSEC and HUVEC models, pre-clinical liver I/R models","journal":"Journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple KLF2 inducers used, genetic/pharmacologic pathway dissection, single lab with in vitro and in vivo validation","pmids":["27545498"],"is_preprint":false},{"year":2018,"finding":"KLF2 directly regulates osteoblast differentiation by binding to and physically interacting with Runx2, promoting Runx2 expression and activity; KLF2 overexpression increases Alp, Osx, Ocn and mineralization while knockdown has opposite effects.","method":"Overexpression and siRNA knockdown in MC3T3-E1 cells and primary osteoblasts, co-immunoprecipitation (KLF2-Runx2 interaction)","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — physical interaction shown by Co-IP, functional gain/loss-of-function with defined differentiation markers, single lab","pmids":["30429507"],"is_preprint":false},{"year":2019,"finding":"KLF2 regulates osteoclastogenesis by modulating Beclin1 (BECN1)-mediated autophagy; KLF2 knockdown increases H3K9 and H4K8 acetylation in the Becn1 promoter region (demonstrated by ChIP), increasing Becn1 expression; KLF2 overexpression reduces these histone acetylation marks and decreases autophagy and osteoclast differentiation.","method":"ChIP assay for histone modifications at Becn1 promoter, adenoviral KLF2 overexpression, siRNA knockdown, 3-methyladenine autophagy inhibition, arthritis mouse model","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — epigenetic mechanism at Becn1 promoter demonstrated by ChIP with histone modification marks, functional validation by gain/loss-of-function, single lab","pmids":["30894058"],"is_preprint":false},{"year":2015,"finding":"PIEZO1 mechanosensitive channel mediates shear stress-induced KLF2/4 expression through a CaMKII-MEKK3-ERK5 signaling axis: shear stress activates PIEZO1, causing calcium influx that activates CaMKII, which interacts with and activates MEKK3, promoting MEKK3/MEK5/ERK5 signaling to induce KLF2/4 transcription; endothelial-specific Piezo1 deletion reduces KLF2/4 expression in vivo.","method":"Endothelial-specific Piezo1 knockout mice, PIEZO1 receptor antagonist, siRNA, CaMKII interaction/activation assays, shear stress experiments","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic KO plus in vitro signaling pathway dissection, CaMKII-MEKK3 interaction demonstrated, single lab","pmids":["35883633"],"is_preprint":false},{"year":2015,"finding":"P2X4 purinergic receptor mediates shear stress-induced KLF2 expression in endothelial cells; shear-induced ATP release activates P2X4, promoting ERK5 phosphorylation and KLF2 upregulation; a loss-of-function P2X4 variant (Tyr315>Cys) blocks ATP-induced KLF2 expression.","method":"siRNA knockdown of P2X4, pharmacological P2X4 antagonist, transient transfection of mutant P2X4, HUVEC shear stress experiments","journal":"Purinergic signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA, pharmacological, and mutation-based evidence; single lab with multiple approaches","pmids":["25563726"],"is_preprint":false},{"year":2017,"finding":"Endothelial KLF2 mediates protection against cardiac maladaptive remodeling via a Klf2-Foxp1-TGFβ1 pathway; endothelial-specific KLF2 inhibition reverses simvastatin-mediated reduction of fibroblast proliferation and myofibroblast formation; KLF2 directly regulates TGFβ1 and Foxp1 in endothelial cells, and loss of Foxp1 phenocopies KLF2 inhibition.","method":"Endothelial-specific siRNA delivery via RGD-magnetic nanoparticles in vivo, pressure overload model, gene expression analysis, in vitro EC studies","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo endothelial-specific knockdown with defined cardiac phenotype, epistasis via Foxp1 inhibition, single lab","pmids":["33408770"],"is_preprint":false},{"year":2020,"finding":"KLF2 directly promotes Vav1 transcription in adult DRG neurons; increased Vav1 then promotes axon regeneration by activating Rac1 GTPase; Klf2 is induced by retrograde Ca2+ signaling from injured axons, establishing a Klf2-Vav1-Rac1 axis in peripheral nerve regeneration.","method":"RNA-seq after sciatic nerve crush, ChIP for KLF2 at Vav1 promoter, siRNA/overexpression knockdown in DRG neurons, Vav1 KO functional rescue","journal":"Experimental neurology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP, Rac1 GTPase activation assay, single lab with multiple methods","pmids":["34147481"],"is_preprint":false},{"year":2021,"finding":"KLF2 inhibits ferroptosis in clear cell renal cell carcinoma by transcriptionally repressing GPX4; KLF2 deficiency impairs GPX4 repression, promoting migration and invasion; reverting KLF2 expression in vivo decreases pulmonary metastases, and GPX4 overexpression reverses KLF2-mediated anti-metastatic effects.","method":"KLF2 overexpression/knockdown in vitro and in vivo, GPX4 expression analysis, ferroptosis assays, xenograft mouse model","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional manipulation with GPX4 rescue experiment, in vivo validation, single lab","pmids":["34520818"],"is_preprint":false},{"year":2020,"finding":"KLF2 directly binds the IRF4 promoter (demonstrated by dual luciferase reporter gene assay and ChIP) and upregulates IRF4 expression; IRF4 in turn binds the HDAC7 promoter to increase HDAC7 expression, forming a KLF2-IRF4-HDAC7 neuroprotective pathway in hypoxic-ischemic brain damage.","method":"Dual luciferase reporter gene assay, ChIP, adenoviral KLF2 overexpression, in vivo HIBD rat model, OGD neuron model","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct promoter binding demonstrated by ChIP and reporter assay, in vivo and in vitro validation, single lab","pmids":["35091544"],"is_preprint":false},{"year":2019,"finding":"IRF2BP2 regulates KLF2 expression; KLF2 overexpression in osteoclast precursors inhibits osteoclast differentiation by downregulating c-Fos, NFATc1, and TRAP, while KLF2 overexpression in osteoblasts enhances differentiation by upregulating Runx2, ALP, and BSP; IRF2BP2 effects on bone cells are reversed by KLF2 downregulation.","method":"Overexpression and siRNA knockdown in osteoclast precursor and osteoblast cell lines, differentiation marker assays, epistasis by KLF2 siRNA rescue","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by KLF2 knockdown reversal of IRF2BP2 effects, bidirectional manipulation, single lab","pmids":["31186082"],"is_preprint":false},{"year":2017,"finding":"Restoring KLF2 expression in the carotid body of heart failure rabbits (via adenoviral transfection) reduces sympathetic nerve activity, arrhythmia incidence, and chemoreflex sensitivity; lentiviral KLF2 siRNA in the carotid body increases chemoreflex sensitivity and sympathetic activation, establishing KLF2 as a regulator of carotid body chemoreflex function.","method":"In vivo adenoviral KLF2 transfection and lentiviral siRNA knockdown in carotid body, measurement of ventilation, renal SNA, ECG, arrhythmia, breathing patterns","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional in vivo manipulation with defined physiological phenotypes, single lab","pmids":["29023738"],"is_preprint":false},{"year":2022,"finding":"KLF2 regulates neutrophil NETosis pathway activated by chronic angiotensin II infusion; mechanistically, KLF2 controls neutrophil activation partly through crosstalk with HIF1 signaling; KLF2-dependent NETosis triggers sporadic thrombosis in small myocardial vessels leading to cardiac hypertrophy.","method":"Mouse model of Ang II-induced cardiac dysfunction, neutrophil-specific KLF2 manipulation, NET/thrombosis targeting, HIF1 signaling analysis","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic model with defined mechanistic pathway (KLF2-NETosis-thrombosis), single lab with multiple pharmacological interventions","pmids":["34793333"],"is_preprint":false},{"year":2020,"finding":"KLF2 regulates chemoreflex-related carotid body function by modulating BDNF/TrkB pathway in microglial cells under oxygen-glucose deprivation; KLF2 overexpression increases BDNF and TrkB levels and protects against OGD-induced apoptosis; these KLF2 effects are blocked by BDNF/TrkB inhibitor K252a, establishing KLF2 upstream of BDNF/TrkB signaling.","method":"Adenoviral KLF2 overexpression in BV2 cells, OGD model, K252a (BDNF/TrkB inhibitor) epistasis, cell viability/apoptosis assays","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single cell-line model, pathway epistasis by pharmacological inhibitor only","pmids":["31821872"],"is_preprint":false},{"year":2021,"finding":"KLF2 inhibits TGF-β/Smad signaling in hepatocellular carcinoma cells by inhibiting the transcriptional activity of Smad2/3 and Smad4, creating a negative feedback loop; stably expressed KLF2 attenuates TGF-β-induced MMP2 upregulation and cancer cell motility.","method":"Luciferase reporter assay for Smad transcriptional activity, stable KLF2 expression, wound-healing and transwell assays, MMP2 expression analysis","journal":"Acta biochimica et biophysica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transcriptional activity assay (luciferase reporter) for Smad inhibition, functional cell motility assays, single lab","pmids":["32318691"],"is_preprint":false},{"year":2020,"finding":"KLF2 induces KLF2-mediated autophagy in dental pulp-derived stem cells (DPSCs) during osteoblast differentiation; ChIP analysis confirmed KLF2 and active epigenetic marks (H3K27Ac and H3K4me3) are upregulated in the ATG7 promoter region during OB differentiation; a metabolic shift from mitochondrial respiration to glycolysis occurs during OB differentiation.","method":"ChIP for KLF2 and histone marks at ATG7 promoter, Seahorse flux analysis, ROS measurements, gain/loss-of-function of KLF2 and autophagy genes (ATG7, BECN1)","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct KLF2 binding at ATG7 promoter by ChIP with histone modification marks, metabolic flux measurements, single lab","pmids":["32777717"],"is_preprint":false},{"year":2024,"finding":"METTL3-mediated N6-methyladenosine (m6A) modification of KLF2 mRNA plays a crucial role in protecting pulmonary artery endothelial cells from EndMT; m6A modification stabilizes KLF2 mRNA; mutations in m6A sites of KLF2 mRNA compromise KLF2 expression and its protective effect; KLF2 modulates SM22 expression through direct binding to its promoter.","method":"RNA methylation quantification, m6A-RIP-qPCR, mRNA stability assay, m6A site mutation, dual-luciferase assay for KLF2 binding to SM22 promoter, endothelial-specific Mettl3 KO mice","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct mRNA modification and promoter binding demonstrated, in vivo KO validation, single lab with multiple methods","pmids":["38741032"],"is_preprint":false},{"year":2017,"finding":"Simvastatin upregulates S1PR1 transcription via KLF2: simvastatin induces KLF2 recruitment to the S1PR1 promoter (demonstrated by ChIP); KLF2 silencing significantly attenuates simvastatin-induced S1PR1 promoter activity and augmented S1PR1 agonist-mediated barrier enhancement.","method":"ChIP for KLF2 at S1PR1 promoter, luciferase reporter assay, siRNA KLF2 knockdown, transendothelial electrical resistance assay, in vivo mouse lung microarray","journal":"Pulmonary circulation","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP, functional rescue by KLF2 siRNA, single lab","pmids":["28680571"],"is_preprint":false},{"year":2025,"finding":"KLF2 is required to suppress the exhaustion-promoting transcription factor TOX and to enable TBET to drive effector differentiation during acute LCMV infection; KLF2 KO results in aberrant differentiation to exhausted-like CD8 T cells during acute infection, and KLF2 is necessary to maintain a polyfunctional tumor-specific progenitor state.","method":"In vivo CRISPR-Cas9-based perturbation sequencing (~40 TFs), KLF2 KO during LCMV infection, TOX and TBET expression analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo CRISPR-based genetic perturbation with defined exhaustion/effector phenotype and mechanistic TF (TOX, TBET) identification","pmids":["39946463"],"is_preprint":false},{"year":2023,"finding":"In CAR T cells, KLF2 acts as a hub transcription factor in the effector gene network and enhances effector CD8+ T cell differentiation while preventing terminal exhaustion; FOXP1 (hub in stem-like network) and KLF2 (hub in effector network) reciprocally regulate checkpoints of stem-like to effector transition.","method":"Single-cell paired chromatin accessibility and transcriptome profiling (ATAC+RNA-seq) in CAR T cells, enhancer network analysis, FOXP1/KLF2 functional perturbations","journal":"Nature immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chromatin accessibility and transcriptome profiling with functional perturbation, single lab","pmids":["38012417"],"is_preprint":false},{"year":2019,"finding":"KLF2 directly regulates osteoclastogenesis and osteoblast differentiation; IRF2BP2 overexpression suppresses osteoclast differentiation and enhances osteoblast differentiation through KLF2; effects are reversed by downregulating KLF2, establishing IRF2BP2-KLF2 as a regulatory axis in bone homeostasis.","method":"Overexpression and siRNA knockdown of IRF2BP2 and KLF2 in bone cells, epistasis rescue, differentiation marker assays","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by KLF2 siRNA reversal of IRF2BP2 effects, bidirectional manipulation, single lab","pmids":["31186082"],"is_preprint":false},{"year":2019,"finding":"KLF2 interacts with FOXO4 and cooperates with FOXO4 to induce p21 expression and cellular senescence in pancreatic cancer cells; downregulation of either p21 or FOXO4 impairs KLF2-induced senescence.","method":"Co-immunoprecipitation (KLF2-FOXO4 interaction), KLF2 overexpression/knockdown, p21 and FOXO4 siRNA knockdown, senescence assays","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — physical interaction by Co-IP, functional epistasis via FOXO4/p21 knockdown, single lab","pmids":["31866399"],"is_preprint":false},{"year":2021,"finding":"KLF2 interacts with hexokinase 1 (HK1) and inhibits HK1-mediated glucose metabolism reprogramming, thereby suppressing endothelial-to-mesenchymal transition (EndMT); KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification through this KLF2/HK1 axis.","method":"Co-immunoprecipitation (KLF2-HK1 interaction), HK1 knockdown, KLF2 overexpression/knockdown, glycolysis measurements in HUVECs","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — physical interaction by Co-IP, functional knockdown with metabolic readouts, single lab","pmids":["34363795","33253911"],"is_preprint":false},{"year":2015,"finding":"KLF2 interacts with β-catenin and negatively regulates β-catenin/TCF signaling in pancreatic ductal adenocarcinoma cells, thereby inhibiting cell growth and migration.","method":"Co-immunoprecipitation (KLF2-β-catenin), overexpression in PDAC cells, TCF reporter assay, migration/growth assays","journal":"Tumour biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP, single lab, limited mechanistic follow-up","pmids":["26449825"],"is_preprint":false},{"year":2021,"finding":"In zebrafish, klf2a and klf2b are required for Notch signaling activation in the endocardium and heart regeneration; klf2 gene expression is regulated by primary cilia-dependent mechanosensing of blood flow changes, placing klf2 downstream of primary cilia in a cilia-klf2-Notch axis.","method":"Zebrafish heart regeneration model, klf2a/klf2b morpholino knockdown, primary cilia mutants, Notch reporter assays","journal":"Protein & cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in zebrafish with cilia and Notch pathway readouts, single lab","pmids":["32249387"],"is_preprint":false},{"year":2021,"finding":"In zebrafish valvulogenesis, Erk5-Klf2-Wnt9a signaling (activated by shear stress) drives Wnt9a production, which induces ingression of endocardial cells into cardiac jelly to form abluminal cell populations; this mechanosensitive Klf2 pathway runs in parallel with Notch-Dll4 lateral inhibition to sculpt valve leaflets.","method":"Zebrafish valvulogenesis model, klf2 and wnt9a genetic/morpholino manipulations, Notch-Dll4 pathway epistasis, live imaging","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in zebrafish with live imaging, pathway placement by parallel manipulation, single lab","pmids":["34610316"],"is_preprint":false}],"current_model":"KLF2 (LKLF) is a zinc-finger transcription factor that directly binds promoters (CACCC/Sp1-3 elements) to transcriptionally activate or repress target genes including eNOS, thrombomodulin, S1PR1, p21, GPX4, PFKFB3, AQP1, IRF4, Vav1, and Becn1; it is activated downstream of a PIEZO1/P2X4-Ca2+-CaMKII-MEKK3-MEK5-ERK5-MEF2 mechanosensory cascade in endothelial cells, and its expression is maintained epigenetically by KDM3A-mediated H3K9 demethylation and by METTL3-dependent m6A stabilization of its mRNA; in T cells, KLF2 programs quiescence by repressing c-Myc, drives effector differentiation while suppressing TOX-dependent exhaustion, and controls trafficking via S1PR1 and CD62L; in endothelium, it coordinately suppresses thrombosis, inflammation, glycolysis (via PFKFB3 repression), and EndMT, and is required with KLF4 for adult vascular integrity; loss-of-function mutations in its zinc-finger domains inactivate its ability to suppress NF-κB-driven signaling and underlie splenic marginal zone lymphoma pathogenesis."},"narrative":{"mechanistic_narrative":"KLF2 (LKLF) is a zinc-finger transcription factor that binds gene promoters to program quiescence, vascular integrity, and cell-fate decisions across hematopoietic, endothelial, and other lineages [PMID:9302292, PMID:15718498]. In the endothelium it serves as the central effector of mechanosensing: laminar shear stress, transduced through PIEZO1 and P2X4-dependent calcium signaling into a CaMKII-MEKK3-MEK5-ERK5 cascade, induces KLF2 transcription [PMID:35883633, PMID:25563726], and KLF2 in turn reprograms the endothelial transcriptome to enforce an antithrombotic, anti-inflammatory, and quiescent state — directly inducing thrombomodulin and eNOS while restraining tissue factor and PAI-1 [PMID:15718498], suppressing proinflammatory genes via ATF2 [PMID:17244683], repressing the glycolytic regulator PFKFB3 to limit angiogenic sprouting [PMID:25359860], and repressing the pro-migratory effector PAK1 [PMID:25388666]. KLF2 and KLF4 act with substantial redundancy to maintain adult vascular integrity, and combined endothelial loss is acutely lethal [PMID:28239661]; aberrant gain of MEKK3-KLF2/KLF4 signaling upon loss of the CCM complex drives cerebral cavernous malformation lesions [PMID:27027284]. In lymphocytes KLF2 programs the quiescent single-positive T-cell state and maintains viability, in part by repressing c-Myc [PMID:9302292, PMID:11477405], controls trafficking through CD62L and the S1P receptor S1PR1 [PMID:21187410, PMID:25692701], restrains T follicular helper differentiation via S1PR1 and Blimp-1/Bcl-6 [PMID:25692701], and is required to suppress the exhaustion factor TOX while enabling TBET-driven effector differentiation in CD8 T cells [PMID:39946463, PMID:38012417]. KLF2 acts as a tumor suppressor in multiple settings, including by repressing GPX4 to license ferroptosis [PMID:34520818] and by antagonizing NF-κB signaling — loss-of-function mutations in its zinc-finger domains that abolish this NF-κB suppression underlie splenic marginal zone lymphoma [PMID:25428260]. KLF2 expression is itself maintained by KDM3A-mediated H3K9 demethylation [PMID:26728187] and METTL3-dependent m6A stabilization of its mRNA [PMID:38741032].","teleology":[{"year":1997,"claim":"Established KLF2's foundational physiological roles by showing it is genetically required both for T-cell quiescence/survival and for vascular wall stabilization during development.","evidence":"Knockout mice with in vivo T-cell phenotyping and vascular morphogenesis analysis by multiple imaging methods","pmids":["9302292","9367982"],"confidence":"High","gaps":["Did not identify the transcriptional targets mediating quiescence or vessel stabilization","Embryonic lethality limited analysis of adult vascular roles"]},{"year":1998,"claim":"Extended the essential developmental requirement to erythropoiesis, showing the closely related EKLF cannot compensate for KLF2 loss.","evidence":"Knockout mouse with in vitro fetal liver erythroid colony assay","pmids":["9859212"],"confidence":"High","gaps":["Direct erythroid target genes not defined in this study","Mechanism of non-redundancy with EKLF unresolved"]},{"year":2001,"claim":"Resolved how KLF2 enforces T-cell quiescence by showing it acts sufficiently and partly through repression of c-Myc.","evidence":"Gain-of-function in Jurkat cells with dominant-negative MadMyc mimicry and c-Myc rescue epistasis","pmids":["11477405"],"confidence":"High","gaps":["Other quiescence effectors beyond c-Myc not enumerated","Direct vs. indirect repression of c-Myc not distinguished"]},{"year":2002,"claim":"Defined KLF2 as a direct promoter-binding repressor by showing it inhibits PPARγ2 transcription to restrain adipogenesis.","evidence":"Reporter assays, promoter mutational analysis, and EMSA in preadipocytes","pmids":["12426306"],"confidence":"High","gaps":["In vivo relevance to adipose biology not tested","Did not address whether repression is direct binding versus cofactor-mediated"]},{"year":2003,"claim":"Placed KLF2 in a signaling pathway by showing TRAF2/p38 controls its expression independent of NF-κB, with anti-apoptotic consequences.","evidence":"Microarray comparison of TRAF2-/- cells with ectopic-expression rescue and pathway inhibitors","pmids":["12897154"],"confidence":"Medium","gaps":["Direct transcriptional control of KLF2 by p38 not demonstrated","Anti-apoptotic targets downstream of KLF2 not identified"]},{"year":2004,"claim":"Identified the cis-element basis of KLF2 antiproliferative activity, mapping induction of p21 to the Sp1-3 site and requiring both activation and inhibitory domains.","evidence":"Tetracycline-inducible expression with luciferase reporter and promoter mutational analysis in Jurkat cells","pmids":["15361832"],"confidence":"High","gaps":["Endogenous p21 regulation by KLF2 in primary cells not tested","Domain contributions to other targets not generalized"]},{"year":2005,"claim":"Established KLF2 as the shear-stress-responsive master regulator of endothelial antithrombotic and vascular-tone programs.","evidence":"Adenoviral overexpression and siRNA knockdown with clotting assays, plus in vivo carotid collar shear model with laser microdissection","pmids":["15718498","16049344"],"confidence":"High","gaps":["Upstream mechanosensors transducing shear to KLF2 not yet defined","Direct promoter occupancy at thrombomodulin/eNOS not shown in these studies"]},{"year":2007,"claim":"Provided a mechanism for KLF2 atheroprotection by showing it suppresses proinflammatory genes via inhibition of ATF2 nuclear binding.","evidence":"Genome-wide profiling, ATF2 nuclear binding assay, and siRNA in HUVEC shear experiments","pmids":["17244683"],"confidence":"Medium","gaps":["Direct biochemical interaction between KLF2 and ATF2 not established","Single-lab finding"]},{"year":2011,"claim":"Demonstrated direct chromatin occupancy of KLF2 at globin regulatory elements, establishing its role in embryonic/fetal globin gene expression.","evidence":"ChIP in primary embryonic blood cells with conditional KO and transgenic human globin locus models","pmids":["21610079"],"confidence":"High","gaps":["Functional separation of KLF1 versus KLF2 contributions incompletely resolved","Cofactors recruited to globin loci not identified"]},{"year":2010,"claim":"Defined KLF2's role in B-cell homeostasis and trafficking via control of CD62L and β7-integrin, revealing lineage-specific differences from T cells.","evidence":"B-cell-specific conditional KO with flow cytometry and gene expression analysis","pmids":["21187410"],"confidence":"High","gaps":["Why S1PR1 is minimally affected in B cells unlike T cells unexplained","Direct targets controlling B1/marginal-zone partitioning not defined"]},{"year":2014,"claim":"Linked KLF2 to endothelial metabolism, showing it represses PFKFB3 to suppress glycolysis and angiogenic sprouting under laminar flow.","evidence":"Seahorse flux, reporter assays, RNA-seq, and endothelial-specific KO with PFKFB3 rescue","pmids":["25359860"],"confidence":"High","gaps":["Whether metabolic and inflammatory programs are independently regulated not resolved","Direct PFKFB3 promoter occupancy by KLF2 not shown"]},{"year":2014,"claim":"Connected KLF2 to disease by defining IKKβ-regulated, CCM-regulated, and mutation-driven control of KLF2 activity in coagulation and lymphoma.","evidence":"ChIP and KLF2 knockdown for IKKβ-thrombomodulin axis; zebrafish CCM epistasis; whole-exome sequencing with NF-κB reporter assays of mutant KLF2","pmids":["25039491","25625207","25428260"],"confidence":"High","gaps":["Mechanism by which zinc-finger mutations specifically lose NF-κB suppression not structurally defined","Direct NF-κB target promoters bound by KLF2 not mapped"]},{"year":2015,"claim":"Resolved the mechanosensory input to KLF2, showing PIEZO1 and P2X4 transduce shear into calcium/CaMKII-MEKK3-ERK5 signaling that drives KLF2 transcription.","evidence":"Endothelial-specific Piezo1 KO, P2X4 siRNA/antagonist and loss-of-function variant, CaMKII-MEKK3 interaction assays in shear experiments","pmids":["35883633","25563726"],"confidence":"Medium","gaps":["Relative contributions of PIEZO1 versus P2X4 not integrated","Single-lab signaling reconstruction"]},{"year":2015,"claim":"Established KLF2 as a checkpoint of T-cell differentiation and trafficking, controlling S1PR1, Blimp-1/Bcl-6, and Tfh versus Th1 fate.","evidence":"Inducible CD4 T-cell deletion and overexpression with in vivo Tfh quantification and gene expression analysis","pmids":["25692701"],"confidence":"High","gaps":["Direct versus indirect induction of Blimp-1, T-bet, GATA3 not all distinguished","Promoter occupancy not shown for all targets"]},{"year":2016,"claim":"Defined the MEKK3-KLF2/4 gain-of-signaling mechanism underlying CCM lesion formation and confirmed KLF2's homeostatic role in NK-cell survival.","evidence":"Neonatal CCM mouse model with endothelial-specific Mekk3/Klf2/Klf4 KO and human lesion staining; NK-cell KO with proliferation/homing assays","pmids":["27027284","27114551"],"confidence":"High","gaps":["Rho-activation link between KLF2 and lesion morphology mechanistically incomplete","NK homing-receptor targets of KLF2 not all defined"]},{"year":2016,"claim":"Identified the epigenetic and autoregulatory circuitry maintaining KLF2, via KDM3A-mediated H3K9 demethylation and a reciprocal KLF2-IRF4 loop in myeloma.","evidence":"siRNA of KDM3A/KLF2/IRF4, H3K9 ChIP, and in vitro/in vivo myeloma models","pmids":["26728187"],"confidence":"High","gaps":["Whether KDM3A directly targets the KLF2 locus versus indirectly not fully resolved","Generality of KLF2-IRF4 loop beyond myeloma unknown"]},{"year":2017,"claim":"Demonstrated that KLF2 and KLF4 together control adult vascular integrity with dosage redundancy, with combined loss being acutely lethal.","evidence":"Inducible endothelial-specific Klf2/Klf4 double KO with transcriptome and coagulation analysis and gene-dosage testing","pmids":["28239661"],"confidence":"High","gaps":["Division of labor between KLF2 and KLF4 at individual targets not resolved","Which transcriptome subset is the lethal driver not pinpointed"]},{"year":2017,"claim":"Expanded KLF2 mechanism into migration, cardiac remodeling, and pharmacologic induction pathways linking statins, autophagy, and S1PR1.","evidence":"Erk5/MEK5 and PAK1 rescue migration assays; endothelial-specific Klf2 manipulation in cardiac remodeling; statin-Rac1-Rab7-autophagy and S1PR1 ChIP studies","pmids":["25388666","33408770","27545498","28680571","27756792"],"confidence":"Medium","gaps":["These axes derive from individual single-lab studies","Integration of autophagy feedback with transcriptional output unresolved"]},{"year":2019,"claim":"Extended KLF2 function to bone, senescence, and protein-interaction mechanisms, including cooperation with FOXO4 and physical interaction with Runx2.","evidence":"Co-IP of KLF2-FOXO4 and KLF2-Runx2, IRF2BP2-KLF2 epistasis in bone cells, and differentiation/senescence assays","pmids":["31866399","30429507","31186082"],"confidence":"Medium","gaps":["Physical interactions rest on single Co-IPs without reciprocal structural validation","In vivo bone phenotypes of KLF2 not established here"]},{"year":2021,"claim":"Established KLF2 as a tumor suppressor and regenerative regulator acting through GPX4-dependent ferroptosis, HK1-dependent metabolism, Vav1-Rac1 axon regrowth, and cilia-Notch cardiac regeneration.","evidence":"KLF2 over/knockdown with GPX4 and HK1 rescue, DRG ChIP/Rac1 assays, and zebrafish cilia/Notch and valvulogenesis epistasis","pmids":["34520818","34363795","34147481","32249387","34610316"],"confidence":"Medium","gaps":["Each axis is single-lab and context-specific","Whether these reflect a shared KLF2 transcriptional logic is unresolved"]},{"year":2024,"claim":"Identified post-transcriptional control of KLF2 by METTL3-dependent m6A stabilization protecting against EndMT, and CRISPR-defined KLF2 as an effector hub suppressing CD8 T-cell exhaustion.","evidence":"m6A-RIP, mRNA stability, m6A-site mutation and endothelial Mettl3 KO; in vivo CRISPR perturbation screen with TOX/TBET analysis and CAR-T chromatin/transcriptome profiling","pmids":["38741032","39946463","38012417"],"confidence":"High","gaps":["Interplay between m6A stabilization and KDM3A epigenetic control not integrated","Direct KLF2 targets enforcing the anti-exhaustion program not fully mapped"]},{"year":null,"claim":"How KLF2 selects between transcriptional activation and repression at individual targets, and how its many context-specific axes (vascular, immune, metabolic, regenerative) reflect a unified set of direct genomic targets, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No genome-wide KLF2 occupancy map integrating cell types reported","Cofactor switching between activation and repression not defined","Division of labor with KLF4 at the locus level unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,6,7,11,12,15,30,31,32,39]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,11,21,22,30,40]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,11,17]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,6,7,11,12,30,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,27,28,37]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,10,15,18,41,42]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[7,21,19,35]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[12,45]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,2,16,47,48]}],"complexes":[],"partners":["KLF4","RUNX2","FOXO4","HK1","MEKK3","IRF4","ATF2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y5W3","full_name":"Krueppel-like factor 2","aliases":["Lung krueppel-like factor"],"length_aa":355,"mass_kda":37.4,"function":"Transcription factor that binds to the CACCC box in the promoter of target genes such as HBB/beta globin or NOV and activates their transcription (PubMed:21063504). Might be involved in transcriptional regulation by modulating the binding of the RARA nuclear receptor to RARE DNA elements (PubMed:28167758)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y5W3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KLF2","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KLF2","total_profiled":1310},"omim":[{"mim_id":"621228","title":"LONG INTERGENIC NONCODING RNA 1013; LINC01013","url":"https://www.omim.org/entry/621228"},{"mim_id":"620533","title":"LONG INTERGENIC NONCODING RNA 520; LINC00520","url":"https://www.omim.org/entry/620533"},{"mim_id":"609423","title":"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/609423"},{"mim_id":"608582","title":"EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7","url":"https://www.omim.org/entry/608582"},{"mim_id":"607929","title":"CCM2 SCAFFOLD PROTEIN; CCM2","url":"https://www.omim.org/entry/607929"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/KLF2"},"hgnc":{"alias_symbol":["LKLF"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y5W3","domains":[{"cath_id":"3.30.160.60","chopping":"270-300","consensus_level":"medium","plddt":80.0419,"start":270,"end":300}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5W3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5W3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5W3-F1-predicted_aligned_error_v6.png","plddt_mean":56.84},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KLF2","jax_strain_url":"https://www.jax.org/strain/search?query=KLF2"},"sequence":{"accession":"Q9Y5W3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y5W3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y5W3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5W3"}},"corpus_meta":[{"pmid":"9302292","id":"PMC_9302292","title":"LKLF: A transcriptional regulator of single-positive T cell quiescence and survival.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9302292","citation_count":352,"is_preprint":false},{"pmid":"15718498","id":"PMC_15718498","title":"Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15718498","citation_count":324,"is_preprint":false},{"pmid":"9367982","id":"PMC_9367982","title":"The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9367982","citation_count":309,"is_preprint":false},{"pmid":"16049344","id":"PMC_16049344","title":"Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes.","date":"2005","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16049344","citation_count":290,"is_preprint":false},{"pmid":"27027284","id":"PMC_27027284","title":"Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/27027284","citation_count":256,"is_preprint":false},{"pmid":"25359860","id":"PMC_25359860","title":"Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3.","date":"2014","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25359860","citation_count":249,"is_preprint":false},{"pmid":"12426306","id":"PMC_12426306","title":"The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12426306","citation_count":246,"is_preprint":false},{"pmid":"28239661","id":"PMC_28239661","title":"KLF2 and KLF4 control endothelial identity and vascular integrity.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28239661","citation_count":201,"is_preprint":false},{"pmid":"11477405","id":"PMC_11477405","title":"Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11477405","citation_count":184,"is_preprint":false},{"pmid":"25692701","id":"PMC_25692701","title":"The transcription factor KLF2 restrains CD4⁺ T follicular helper cell differentiation.","date":"2015","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25692701","citation_count":168,"is_preprint":false},{"pmid":"29125549","id":"PMC_29125549","title":"KLF2 in Regulation of NF-κB-Mediated Immune Cell Function and Inflammation.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29125549","citation_count":142,"is_preprint":false},{"pmid":"25428260","id":"PMC_25428260","title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.","date":"2014","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/25428260","citation_count":139,"is_preprint":false},{"pmid":"34520818","id":"PMC_34520818","title":"KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/34520818","citation_count":137,"is_preprint":false},{"pmid":"25625207","id":"PMC_25625207","title":"Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins.","date":"2015","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25625207","citation_count":124,"is_preprint":false},{"pmid":"9859212","id":"PMC_9859212","title":"Loss of LKLF function results in embryonic lethality in mice.","date":"1998","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/9859212","citation_count":123,"is_preprint":false},{"pmid":"17244683","id":"PMC_17244683","title":"Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17244683","citation_count":122,"is_preprint":false},{"pmid":"15361832","id":"PMC_15361832","title":"KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15361832","citation_count":105,"is_preprint":false},{"pmid":"27545498","id":"PMC_27545498","title":"Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury.","date":"2016","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/27545498","citation_count":99,"is_preprint":false},{"pmid":"21187410","id":"PMC_21187410","title":"Krüppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21187410","citation_count":98,"is_preprint":false},{"pmid":"24751430","id":"PMC_24751430","title":"The role of the transcription factor KLF2 in vascular development and disease.","date":"2014","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/24751430","citation_count":95,"is_preprint":false},{"pmid":"26728187","id":"PMC_26728187","title":"The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26728187","citation_count":92,"is_preprint":false},{"pmid":"18073411","id":"PMC_18073411","title":"The role of shear stress on ET-1, KLF2, and NOS-3 expression in the developing cardiovascular system of chicken embryos in a venous ligation model.","date":"2007","source":"Physiology (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18073411","citation_count":91,"is_preprint":false},{"pmid":"34793333","id":"PMC_34793333","title":"KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34793333","citation_count":85,"is_preprint":false},{"pmid":"30894058","id":"PMC_30894058","title":"KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30894058","citation_count":85,"is_preprint":false},{"pmid":"19495417","id":"PMC_19495417","title":"N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19495417","citation_count":78,"is_preprint":false},{"pmid":"32132543","id":"PMC_32132543","title":"Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32132543","citation_count":76,"is_preprint":false},{"pmid":"26321140","id":"PMC_26321140","title":"Klf2 and Tfcp2l1, Two Wnt/β-Catenin Targets, Act Synergistically to Induce and Maintain Naive Pluripotency.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26321140","citation_count":76,"is_preprint":false},{"pmid":"30429507","id":"PMC_30429507","title":"KLF2 regulates osteoblast differentiation by targeting of Runx2.","date":"2018","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30429507","citation_count":71,"is_preprint":false},{"pmid":"35203463","id":"PMC_35203463","title":"The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35203463","citation_count":69,"is_preprint":false},{"pmid":"32777717","id":"PMC_32777717","title":"KLF2 regulates dental pulp-derived stem cell differentiation through the induction of mitophagy and altering mitochondrial metabolism.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32777717","citation_count":64,"is_preprint":false},{"pmid":"33253911","id":"PMC_33253911","title":"BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2/HK1 pathway in vascular endothelial cells.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/33253911","citation_count":64,"is_preprint":false},{"pmid":"38012417","id":"PMC_38012417","title":"FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38012417","citation_count":62,"is_preprint":false},{"pmid":"32079517","id":"PMC_32079517","title":"Transcription Factor KLF2 and Its Role in the Regulation of Inflammatory Processes.","date":"2020","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/32079517","citation_count":62,"is_preprint":false},{"pmid":"39946463","id":"PMC_39946463","title":"KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection.","date":"2025","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/39946463","citation_count":56,"is_preprint":false},{"pmid":"27114551","id":"PMC_27114551","title":"Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27114551","citation_count":55,"is_preprint":false},{"pmid":"25388666","id":"PMC_25388666","title":"Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.","date":"2014","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/25388666","citation_count":51,"is_preprint":false},{"pmid":"15607822","id":"PMC_15607822","title":"Identification of LKLF-regulated genes in quiescent CD4+ T lymphocytes.","date":"2005","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15607822","citation_count":49,"is_preprint":false},{"pmid":"35883633","id":"PMC_35883633","title":"Mechanosensitive Channel PIEZO1 Senses Shear Force to Induce KLF2/4 Expression via CaMKII/MEKK3/ERK5 Axis in Endothelial Cells.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35883633","citation_count":48,"is_preprint":false},{"pmid":"34253708","id":"PMC_34253708","title":"The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.","date":"2021","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34253708","citation_count":48,"is_preprint":false},{"pmid":"37147883","id":"PMC_37147883","title":"KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway.","date":"2023","source":"The journal of pathology. Clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/37147883","citation_count":47,"is_preprint":false},{"pmid":"30969479","id":"PMC_30969479","title":"The GLP-1 receptor agonist liraglutide protects against oxidized LDL-induced endothelial inflammation and dysfunction via KLF2.","date":"2019","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/30969479","citation_count":47,"is_preprint":false},{"pmid":"30928399","id":"PMC_30928399","title":"KLF2 regulates eNOS uncoupling via Nrf2/HO-1 in endothelial cells under hypoxia and reoxygenation.","date":"2019","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/30928399","citation_count":46,"is_preprint":false},{"pmid":"29608878","id":"PMC_29608878","title":"Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2.","date":"2018","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/29608878","citation_count":45,"is_preprint":false},{"pmid":"35552354","id":"PMC_35552354","title":"Ferutinin induces osteoblast differentiation of DPSCs via induction of KLF2 and autophagy/mitophagy.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35552354","citation_count":45,"is_preprint":false},{"pmid":"25672609","id":"PMC_25672609","title":"SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25672609","citation_count":45,"is_preprint":false},{"pmid":"34696279","id":"PMC_34696279","title":"Krüppel-like Factor 2 (KLF2) in Immune Cell Migration.","date":"2021","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/34696279","citation_count":44,"is_preprint":false},{"pmid":"38099436","id":"PMC_38099436","title":"HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells.","date":"2023","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/38099436","citation_count":43,"is_preprint":false},{"pmid":"27756792","id":"PMC_27756792","title":"A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.","date":"2016","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/27756792","citation_count":42,"is_preprint":false},{"pmid":"34713437","id":"PMC_34713437","title":"Calycosin ameliorates atherosclerosis by enhancing autophagy via regulating the interaction between KLF2 and MLKL in apolipoprotein E gene-deleted mice.","date":"2021","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34713437","citation_count":41,"is_preprint":false},{"pmid":"32249387","id":"PMC_32249387","title":"Primary cilia mediate Klf2-dependant Notch activation in regenerating heart.","date":"2020","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/32249387","citation_count":40,"is_preprint":false},{"pmid":"25563726","id":"PMC_25563726","title":"Shear stress modulates endothelial KLF2 through activation of P2X4.","date":"2015","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25563726","citation_count":40,"is_preprint":false},{"pmid":"21610079","id":"PMC_21610079","title":"Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal beta-globin genes through direct promoter binding.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21610079","citation_count":39,"is_preprint":false},{"pmid":"34610316","id":"PMC_34610316","title":"Mechanosensitive Notch-Dll4 and Klf2-Wnt9 signaling pathways intersect in guiding valvulogenesis in zebrafish.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34610316","citation_count":35,"is_preprint":false},{"pmid":"37705747","id":"PMC_37705747","title":"FGF2 Alleviates Microvascular Ischemia-Reperfusion Injury by KLF2-mediated Ferroptosis Inhibition and Antioxidant Responses.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37705747","citation_count":33,"is_preprint":false},{"pmid":"28628187","id":"PMC_28628187","title":"KLF2 inhibits cell growth via regulating HIF-1α/Notch-1 signal pathway in human colorectal cancer HCT116 cells.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28628187","citation_count":33,"is_preprint":false},{"pmid":"33408770","id":"PMC_33408770","title":"Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33408770","citation_count":33,"is_preprint":false},{"pmid":"32800946","id":"PMC_32800946","title":"KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma.","date":"2020","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32800946","citation_count":32,"is_preprint":false},{"pmid":"37347764","id":"PMC_37347764","title":"Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice.","date":"2023","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/37347764","citation_count":31,"is_preprint":false},{"pmid":"32318691","id":"PMC_32318691","title":"KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma.","date":"2020","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/32318691","citation_count":30,"is_preprint":false},{"pmid":"29079188","id":"PMC_29079188","title":"KLF2 attenuates bleomycin-induced pulmonary fibrosis and inflammation with regulation of AP-1.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29079188","citation_count":30,"is_preprint":false},{"pmid":"31025534","id":"PMC_31025534","title":"Klf4, Klf2, and Zfp148 activate autophagy-related genes in smooth muscle cells during aortic aneurysm formation.","date":"2019","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/31025534","citation_count":30,"is_preprint":false},{"pmid":"30520325","id":"PMC_30520325","title":"KLF2 Inhibits the Migration and Invasion of Prostate Cancer Cells by Downregulating MMP2.","date":"2018","source":"American journal of men's health","url":"https://pubmed.ncbi.nlm.nih.gov/30520325","citation_count":29,"is_preprint":false},{"pmid":"33915432","id":"PMC_33915432","title":"Metformin attenuates atherosclerosis and plaque vulnerability by upregulating KLF2-mediated autophagy in apoE-/- mice.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33915432","citation_count":29,"is_preprint":false},{"pmid":"26449825","id":"PMC_26449825","title":"KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26449825","citation_count":29,"is_preprint":false},{"pmid":"31186082","id":"PMC_31186082","title":"The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation.","date":"2019","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/31186082","citation_count":28,"is_preprint":false},{"pmid":"24874925","id":"PMC_24874925","title":"KLF2--a negative regulator of pre-B cell clonal expansion and B cell activation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24874925","citation_count":28,"is_preprint":false},{"pmid":"29023738","id":"PMC_29023738","title":"KLF2 mediates enhanced chemoreflex sensitivity, disordered breathing and autonomic dysregulation in heart failure.","date":"2017","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29023738","citation_count":28,"is_preprint":false},{"pmid":"34041583","id":"PMC_34041583","title":"Chrysin boosts KLF2 expression through suppression of endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection.","date":"2021","source":"European journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/34041583","citation_count":27,"is_preprint":false},{"pmid":"31821872","id":"PMC_31821872","title":"KLF2 protects BV2 microglial cells against oxygen and glucose deprivation injury by modulating BDNF/TrkB pathway.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31821872","citation_count":27,"is_preprint":false},{"pmid":"12897154","id":"PMC_12897154","title":"TRAF2 exerts its antiapoptotic effect by regulating the expression of Krüppel-like factor LKLF.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12897154","citation_count":26,"is_preprint":false},{"pmid":"25780089","id":"PMC_25780089","title":"Disturbed shear stress reduces Klf2 expression in arterial-venous fistulae in vivo.","date":"2015","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/25780089","citation_count":26,"is_preprint":false},{"pmid":"38741032","id":"PMC_38741032","title":"N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.","date":"2024","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/38741032","citation_count":25,"is_preprint":false},{"pmid":"32739175","id":"PMC_32739175","title":"Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.","date":"2020","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32739175","citation_count":25,"is_preprint":false},{"pmid":"38971122","id":"PMC_38971122","title":"Engineering microvascular networks using a KLF2 reporter to probe flow-dependent endothelial cell function.","date":"2024","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/38971122","citation_count":23,"is_preprint":false},{"pmid":"32191808","id":"PMC_32191808","title":"The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/32191808","citation_count":23,"is_preprint":false},{"pmid":"32416217","id":"PMC_32416217","title":"DT-13 induced apoptosis and promoted differentiation of acute myeloid leukemia cells by activating AMPK-KLF2 pathway.","date":"2020","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/32416217","citation_count":23,"is_preprint":false},{"pmid":"22166808","id":"PMC_22166808","title":"Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells.","date":"2011","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/22166808","citation_count":22,"is_preprint":false},{"pmid":"36693535","id":"PMC_36693535","title":"Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling.","date":"2023","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/36693535","citation_count":21,"is_preprint":false},{"pmid":"25039491","id":"PMC_25039491","title":"IKKβ regulates endothelial thrombomodulin in a Klf2-dependent manner.","date":"2014","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/25039491","citation_count":21,"is_preprint":false},{"pmid":"28130053","id":"PMC_28130053","title":"Vascular protective effects of KLF2 on Aβ-induced toxicity: Implications for Alzheimer's disease.","date":"2017","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/28130053","citation_count":21,"is_preprint":false},{"pmid":"25150253","id":"PMC_25150253","title":"Krüppel-like transcription factors KLF1 and KLF2 have unique and coordinate roles in regulating embryonic erythroid precursor maturation.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/25150253","citation_count":21,"is_preprint":false},{"pmid":"34363795","id":"PMC_34363795","title":"G protein-coupled estrogen receptor regulates the KLF2-dependent eNOS expression by activating of Ca2+ and EGFR signaling pathway in human endothelial cells.","date":"2021","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34363795","citation_count":21,"is_preprint":false},{"pmid":"26717516","id":"PMC_26717516","title":"Expression of Nitric Oxide-Transporting Aquaporin-1 Is Controlled by KLF2 and Marks Non-Activated Endothelium In Vivo.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26717516","citation_count":20,"is_preprint":false},{"pmid":"33946046","id":"PMC_33946046","title":"Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33946046","citation_count":20,"is_preprint":false},{"pmid":"39467260","id":"PMC_39467260","title":"CircFndc3b Mediates Exercise-Induced Neuroprotection by Mitigating Microglial/Macrophage Pyroptosis via the ENO1/KLF2 Axis in Stroke Mice.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39467260","citation_count":19,"is_preprint":false},{"pmid":"35091544","id":"PMC_35091544","title":"KLF2 up-regulates IRF4/HDAC7 to protect neonatal rats from hypoxic-ischemic brain damage.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35091544","citation_count":19,"is_preprint":false},{"pmid":"34120407","id":"PMC_34120407","title":"MiR-144-induced KLF2 inhibition and NF-kappaB/CXCR1 activation promote neutrophil extracellular trap-induced transfusion-related acute lung injury.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34120407","citation_count":19,"is_preprint":false},{"pmid":"31721356","id":"PMC_31721356","title":"KLF2+ stemness maintains human mesenchymal stem cells in bone regeneration.","date":"2019","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/31721356","citation_count":19,"is_preprint":false},{"pmid":"28978525","id":"PMC_28978525","title":"AMPK-KLF2 signaling pathway mediates the proangiogenic effect of erythropoietin in endothelial colony-forming cells.","date":"2017","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28978525","citation_count":19,"is_preprint":false},{"pmid":"35322532","id":"PMC_35322532","title":"miR-126-5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35322532","citation_count":19,"is_preprint":false},{"pmid":"34147481","id":"PMC_34147481","title":"Klf2-Vav1-Rac1 axis promotes axon regeneration after peripheral nerve injury.","date":"2021","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34147481","citation_count":19,"is_preprint":false},{"pmid":"35364229","id":"PMC_35364229","title":"KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification by inhibiting HK1 induced endothelial-to-mesenchymal transition.","date":"2022","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/35364229","citation_count":19,"is_preprint":false},{"pmid":"39375377","id":"PMC_39375377","title":"TRβ activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2 and CEBPA.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39375377","citation_count":18,"is_preprint":false},{"pmid":"35245372","id":"PMC_35245372","title":"Endothelial MEKK3-KLF2/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35245372","citation_count":18,"is_preprint":false},{"pmid":"33232606","id":"PMC_33232606","title":"Betulinic Acid Induces eNOS Expression via the AMPK-Dependent KLF2 Signaling Pathway.","date":"2020","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33232606","citation_count":18,"is_preprint":false},{"pmid":"32016968","id":"PMC_32016968","title":"Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32016968","citation_count":18,"is_preprint":false},{"pmid":"36878047","id":"PMC_36878047","title":"Calenduloside e modulates macrophage polarization via KLF2-regulated glycolysis, contributing to attenuates atherosclerosis.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36878047","citation_count":18,"is_preprint":false},{"pmid":"31866399","id":"PMC_31866399","title":"KLF2 induces the senescence of pancreatic cancer cells by cooperating with FOXO4 to upregulate p21.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31866399","citation_count":17,"is_preprint":false},{"pmid":"33977234","id":"PMC_33977234","title":"Inhibition of the HEG1-KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cells.","date":"2021","source":"FASEB bioAdvances","url":"https://pubmed.ncbi.nlm.nih.gov/33977234","citation_count":16,"is_preprint":false},{"pmid":"28680571","id":"PMC_28680571","title":"Simvastatin-induced sphingosine 1-phosphate receptor 1 expression is KLF2-dependent in human lung endothelial cells.","date":"2017","source":"Pulmonary circulation","url":"https://pubmed.ncbi.nlm.nih.gov/28680571","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54133,"output_tokens":12435,"usd":0.174462,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23682,"output_tokens":6442,"usd":0.13973,"stage2_stop_reason":"end_turn"},"total_usd":0.314192,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"LKLF/KLF2 is required to program the quiescent state of single-positive T cells and maintain their viability; LKLF-deficient T cells produced by gene targeting had a spontaneously activated phenotype and died from Fas ligand-induced apoptosis in peripheral lymphoid organs.\",\n      \"method\": \"Gene targeting (knockout mouse), in vivo phenotypic analysis of T cell activation and apoptosis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with defined cellular phenotype (spontaneous activation, Fas-mediated apoptosis), replicated in same study with multiple readouts\",\n      \"pmids\": [\"9302292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LKLF/KLF2 expressed in vascular endothelial cells is required for tunica media formation and vessel wall stabilization; LKLF-deficient embryos die from hemorrhage with defects in smooth muscle cell organization, reduced pericytes, and decreased extracellular matrix deposition in vessel walls.\",\n      \"method\": \"Homologous recombination (knockout mouse), in situ hybridization, immunohistochemistry, electron microscopy\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined vascular morphogenesis phenotype, multiple orthogonal methods in one study\",\n      \"pmids\": [\"9367982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Loss of LKLF/KLF2 causes embryonic lethality with abdominal bleeding, craniofacial abnormalities, and failure of fetal liver erythroid colony formation in vitro, establishing an essential and non-redundant role in embryonic erythropoiesis that cannot be compensated by the closely related EKLF.\",\n      \"method\": \"Gene targeting (knockout mouse), in vitro fetal liver erythroid colony assay\",\n      \"journal\": \"Transgenic research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined phenotype, complementary in vitro functional assay, replicates LKLF vascular KO findings independently\",\n      \"pmids\": [\"9859212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Forced expression of LKLF/KLF2 in Jurkat T cells is sufficient to program a quiescent phenotype (decreased proliferation, reduced cell size, decreased activation markers) partly by decreasing c-Myc expression; the effects of LKLF are mimicked by dominant-negative MadMyc and rescued by c-Myc overexpression.\",\n      \"method\": \"Retroviral/plasmid overexpression in Jurkat cells, dominant-negative rescue, gene targeting KO for complementation\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function and epistasis rescue experiments, replicated with KO model, multiple orthogonal readouts\",\n      \"pmids\": [\"11477405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"KLF2 directly inhibits PPARγ2 promoter activity (70% inhibition) by binding a specific site in the PPARγ2 promoter, thereby acting as a negative regulator of adipogenesis by repressing PPARγ as well as downstream factors C/EBPα and SREBP1c; KLF2 had no effect on upstream C/EBPβ or C/EBPδ.\",\n      \"method\": \"Transient transfection reporter assay, promoter mutational analysis, gel mobility shift assay (EMSA), overexpression in preadipocytes and primary cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding demonstrated by EMSA and mutational analysis, functional reporter assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12426306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TRAF2 regulates LKLF/KLF2 expression through the p38 MAP kinase pathway (not via TNF signaling or NF-κB); ectopic LKLF expression in TRAF2-deficient cells protected against TNF-induced apoptosis, placing LKLF downstream of TRAF2/p38 in an anti-apoptotic pathway.\",\n      \"method\": \"Microarray gene expression comparison of TRAF2−/− vs. WT cells, ectopic expression rescue, pathway inhibitor analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by rescue experiment and pathway inhibitor, single lab with two orthogonal methods\",\n      \"pmids\": [\"12897154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"KLF2 inhibits proliferation of Jurkat T leukemia cells by upregulating p21WAF1/CIP1 expression; the functional responsive element in the p21 promoter is the Sp1-3 binding site (not the CACCC site), and both activation and inhibitory domains of KLF2 are required for this effect.\",\n      \"method\": \"Tetracycline-inducible expression system, 3H-thymidine uptake assay, luciferase reporter assay, promoter deletion/mutation analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding and transcriptional activation characterized by reporter assay with mutational analysis, multiple cell lines tested\",\n      \"pmids\": [\"15361832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KLF2 regulates endothelial thrombotic function by transcriptionally inducing thrombomodulin and eNOS, reducing PAI-1, and inhibiting cytokine-induced tissue factor expression; siRNA knockdown of KLF2 reduces antithrombotic gene expression and reduces blood clotting time in functional clotting assays.\",\n      \"method\": \"Adenoviral overexpression, siRNA knockdown, gene expression analysis, in vitro clotting assays\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional manipulation (overexpression and knockdown) with functional clotting assay readout, multiple target genes validated\",\n      \"pmids\": [\"15718498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KLF2 (LKLF) is regulated by shear stress in vivo at high-shear arterial sites and acts as a transcriptional regulator of vascular tone genes; KLF2 repression by siRNA suppressed the flow response of endothelin-1, adrenomedullin, and eNOS, establishing KLF2 as a downstream mediator of the shear stress-to-gene expression axis.\",\n      \"method\": \"Carotid artery collar model (in vivo), siRNA knockdown, in situ hybridization, laser microdissection/RT-PCR, shear stress chamber experiments\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo and in vitro validated, siRNA functional knockdown with defined gene expression phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"16049344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"KLF2 inhibits proinflammatory gene expression in endothelial cells under laminar shear stress by suppressing nuclear binding activity of ATF2; siRNA knockdown of ATF2 suppressed basal proinflammatory gene expression under no-flow conditions, placing KLF2-mediated ATF2 inhibition as the mechanism of atheroprotection.\",\n      \"method\": \"Genome-wide expression profiling, promoter analysis, ATF2 nuclear binding activity assay, siRNA knockdown, HUVEC shear stress experiments\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple gene expression methods plus nuclear binding assay, single lab, siRNA validation of KLF2-ATF2 link\",\n      \"pmids\": [\"17244683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"B cell-specific KLF2 deficiency leads to decreased expression of trafficking molecules CD62L and β7-integrin, a drastic reduction in the B1 B-cell pool, increased transitional and marginal zone B-cell numbers, increased apoptosis, and impaired proliferation after BCR cross-linking; S1PR1 expression was unexpectedly minimally altered in B cells.\",\n      \"method\": \"B cell-specific conditional KO mouse, flow cytometry, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific genetic KO with multiple defined phenotypic readouts (subset numbers, apoptosis, proliferation, trafficking molecule expression)\",\n      \"pmids\": [\"21187410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KLF1 and KLF2 directly bind the promoters of human ε- and γ-globin genes, mouse Ey- and βh1-globin genes, and the β-globin locus control region in embryonic blood cells, positively regulating embryonic and fetal β-globin gene expression; KLF1 loss reduces H3K9Ac and H3K4me3 marks at these loci.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) with embryonic blood cells, conditional KO mouse models, dual transgenic human β-globin locus mouse model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct promoter binding established by ChIP in primary cells, genetic KO complementation, histone modification analysis, multiple loci validated\",\n      \"pmids\": [\"21610079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KLF2 represses PFKFB3 promoter activity, thereby inhibiting endothelial glycolysis under laminar shear stress; KLF2 overexpression reduces glucose uptake, glycolytic enzyme expression (PFKFB3, PFK-1, HK2), and angiogenic sprouting, effects partially reversed by PFKFB3 overexpression.\",\n      \"method\": \"Seahorse flux analysis, glucose uptake assays, RNA sequencing, luciferase reporter assay, siRNA/overexpression, endothelial-specific KLF2 KO mouse\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct promoter activity assay, in vitro metabolic flux measurements, in vivo KO validation, epistasis rescue with PFKFB3 overexpression\",\n      \"pmids\": [\"25359860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In zebrafish, loss of CCM proteins upregulates klf2 mRNA through a β1 integrin-dependent mechanism (independent of blood flow), which causes enhanced egfl7 expression and angiogenic signaling; downregulation of β1 integrin rescues CCM cardiovascular malformations, establishing a β1 integrin-Klf2-Egfl7 pathway regulated by CCM proteins.\",\n      \"method\": \"Zebrafish CCM morpholino/mutant model, HUVEC siRNA knockdown, in vivo rescue experiments\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in zebrafish with in vitro mechanistic follow-up in human ECs, single lab\",\n      \"pmids\": [\"25625207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KLF2 mutations in splenic marginal zone lymphoma (predominantly in the C-terminal zinc finger domains) inactivate the ability of KLF2 to suppress NF-κB activation by TLR, BCR, BAFFR, and TNFR signaling, as shown by functional assays.\",\n      \"method\": \"Whole exome sequencing, functional NF-κB reporter assays with mutant KLF2 constructs\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay validating mechanistic consequence of mutations, single lab\",\n      \"pmids\": [\"25428260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KLF2 restrains CD4+ T follicular helper (Tfh) cell differentiation through two mechanisms: (1) promoting S1PR1 expression to control T cell localization (S1PR1 downregulation is required for Tfh generation), and (2) inducing Blimp-1 expression which represses Bcl-6, thereby impairing Tfh differentiation; KLF2 also induces T-bet and GATA3 to enhance Th1 differentiation.\",\n      \"method\": \"Inducible KLF2 deletion in activated CD4+ T cells, KLF2 overexpression, gene expression analysis, in vivo Tfh quantification\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional genetic manipulation (KO and overexpression) with multiple mechanistic readouts (S1PR1, Blimp-1, Bcl-6, T-bet, GATA3), defined cellular phenotype\",\n      \"pmids\": [\"25692701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCM disease pathogenesis involves gain of MEKK3-KLF2/4 signaling: loss of CCM complex (KRIT1, CCM2, PDCD10) increases MEKK3 kinase activity which elevates KLF2 and KLF4 expression and Rho activity in endothelial cells of CCM lesions; endothelial-specific loss of Mekk3, Klf2, or Klf4 prevents lesion formation and rescues lethality in a neonatal mouse CCM model.\",\n      \"method\": \"Neonatal mouse CCM model, endothelial-specific conditional KO of Mekk3/Klf2/Klf4, human CCM lesion immunostaining, CCM2 disease-causing mutation analysis (abrogates MEKK3 interaction)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent genetic KOs in mouse model, human tissue validation, disease mutation functional characterization, replicated across multiple CCM models\",\n      \"pmids\": [\"27027284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"KDM3A histone demethylase maintains KLF2 expression through H3K9 demethylation at the KLF2 locus; KLF2 directly activates IRF4 transcription, and IRF4 reciprocally upregulates KLF2, forming a positive autoregulatory circuit; KLF2 silencing triggers apoptosis in multiple myeloma cells and decreases ITGB7-dependent cell adhesion to bone marrow stromal cells.\",\n      \"method\": \"siRNA knockdown (KDM3A, KLF2, IRF4), ChIP for H3K9 methylation, in vitro and in vivo MM models, gene expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — histone modification ChIP, multiple siRNA knockdowns with defined apoptosis and adhesion phenotypes, in vivo validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"26728187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"KLF2 is a transcription factor required for homeostatic NK cell proliferation and survival; KLF2 deficiency promotes spontaneous proliferation of immature NK cells and regulates a subset of homing receptors that allow mature NK cells to access IL-15-rich microenvironments; KLF2-deficient NK cells undergo apoptosis due to IL-15 starvation.\",\n      \"method\": \"Gene-targeted KO mouse models, ex vivo NK cell proliferation assays, homing receptor expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined proliferation, survival and homing receptor phenotypes, multiple experimental approaches\",\n      \"pmids\": [\"27114551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Inducible endothelial-specific deletion of both Klf2 and Klf4 (EC-DKO) causes acute death from myocardial infarction, heart failure, and stroke with profound compromise of vascular integrity and dysregulation of the coagulation system; a single allele of either gene is sufficient for survival, establishing that KLF2 and KLF4 together control a large segment of the endothelial transcriptome essential for vascular integrity.\",\n      \"method\": \"Inducible endothelial-specific double KO mouse (Klf2/Klf4), transcriptome analysis, coagulation assays\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible cell-type-specific double KO with lethal phenotype and defined molecular/coagulation readouts, gene dosage analysis\",\n      \"pmids\": [\"28239661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KLF2 inhibits endothelial cell migration by KLF2-dependent transcriptional repression of PAK1 (a pro-migratory Rac/Cdc42 mediator); Erk5 activation (via constitutively active MEK5, statins, or shear stress) decreases PAK1 mRNA and protein through KLF2 but not KLF4; PAK1 re-expression or KLF2 knockdown restores migration in Erk5-activated ECs.\",\n      \"method\": \"Constitutively active MEK5 expression, siRNA knockdown (KLF2, KLF4), PAK1 re-expression rescue, migration assays, statin/shear stress treatment\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by rescue experiment (PAK1 re-expression restores migration), KLF2-specific vs. KLF4 discrimination by siRNA, single lab\",\n      \"pmids\": [\"25388666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IKKβ inhibition increases thrombomodulin (TM) expression and function through a KLF2-dependent mechanism: IKKβ inhibition causes KLF2 overexpression and enhanced KLF2 binding to the TM promoter (demonstrated by ChIP); KLF2 knockdown completely attenuates IKKβ-inhibition-mediated TM upregulation.\",\n      \"method\": \"IKKβ chemical inhibitors, siRNA/shRNA knockdown, ChIP assay, luciferase reporter assay, flow cytometry, APC generation assay\",\n      \"journal\": \"Journal of thrombosis and haemostasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP, functional rescue by KLF2 knockdown, multiple methods for TM quantification in single lab\",\n      \"pmids\": [\"25039491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KLF2 directly binds the AQP1 (aquaporin-1) promoter (demonstrated by ChIP) and positively regulates AQP1 expression in endothelial cells; inflammatory stimuli repress AQP1 in an effect restrained by KLF2 overexpression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), KLF2 overexpression, siRNA, gene expression profiling, immunohistochemistry in human vascular tissue\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP, functional validation by overexpression/siRNA, single lab\",\n      \"pmids\": [\"26717516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-302-367 downregulates Erk1/2, which increases KLF2 expression, which in turn upregulates S1PR1 and VE-cadherin, suppressing angiogenesis and improving vascular stability; this Erk1/2-Klf2-S1pr1 pathway was validated by genetic S1pr1 deletion which reversed the antiangiogenic effects of miR-302-367.\",\n      \"method\": \"Endothelial-specific miR302-367 overexpression in mice, S1pr1 genetic deletion, retinal angiogenesis assay, tumor angiogenesis models\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo (S1pr1 KO rescue), pathway placement by sequential knockdown, single lab\",\n      \"pmids\": [\"27756792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Simvastatin activates KLF2 expression through a Rac1-Rab7-autophagy dependent mechanism; KLF2 induction in turn promotes further activation of autophagy, forming a positive feedback loop; this autophagy-KLF2 relationship modulates endothelial phenotype and survival in acute liver injury.\",\n      \"method\": \"Pharmacological inhibition (GGTI-298, statins, resveratrol), adenoviral KLF2 overexpression, autophagic flux assays, LSEC and HUVEC models, pre-clinical liver I/R models\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple KLF2 inducers used, genetic/pharmacologic pathway dissection, single lab with in vitro and in vivo validation\",\n      \"pmids\": [\"27545498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"KLF2 directly regulates osteoblast differentiation by binding to and physically interacting with Runx2, promoting Runx2 expression and activity; KLF2 overexpression increases Alp, Osx, Ocn and mineralization while knockdown has opposite effects.\",\n      \"method\": \"Overexpression and siRNA knockdown in MC3T3-E1 cells and primary osteoblasts, co-immunoprecipitation (KLF2-Runx2 interaction)\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — physical interaction shown by Co-IP, functional gain/loss-of-function with defined differentiation markers, single lab\",\n      \"pmids\": [\"30429507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KLF2 regulates osteoclastogenesis by modulating Beclin1 (BECN1)-mediated autophagy; KLF2 knockdown increases H3K9 and H4K8 acetylation in the Becn1 promoter region (demonstrated by ChIP), increasing Becn1 expression; KLF2 overexpression reduces these histone acetylation marks and decreases autophagy and osteoclast differentiation.\",\n      \"method\": \"ChIP assay for histone modifications at Becn1 promoter, adenoviral KLF2 overexpression, siRNA knockdown, 3-methyladenine autophagy inhibition, arthritis mouse model\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — epigenetic mechanism at Becn1 promoter demonstrated by ChIP with histone modification marks, functional validation by gain/loss-of-function, single lab\",\n      \"pmids\": [\"30894058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PIEZO1 mechanosensitive channel mediates shear stress-induced KLF2/4 expression through a CaMKII-MEKK3-ERK5 signaling axis: shear stress activates PIEZO1, causing calcium influx that activates CaMKII, which interacts with and activates MEKK3, promoting MEKK3/MEK5/ERK5 signaling to induce KLF2/4 transcription; endothelial-specific Piezo1 deletion reduces KLF2/4 expression in vivo.\",\n      \"method\": \"Endothelial-specific Piezo1 knockout mice, PIEZO1 receptor antagonist, siRNA, CaMKII interaction/activation assays, shear stress experiments\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic KO plus in vitro signaling pathway dissection, CaMKII-MEKK3 interaction demonstrated, single lab\",\n      \"pmids\": [\"35883633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"P2X4 purinergic receptor mediates shear stress-induced KLF2 expression in endothelial cells; shear-induced ATP release activates P2X4, promoting ERK5 phosphorylation and KLF2 upregulation; a loss-of-function P2X4 variant (Tyr315>Cys) blocks ATP-induced KLF2 expression.\",\n      \"method\": \"siRNA knockdown of P2X4, pharmacological P2X4 antagonist, transient transfection of mutant P2X4, HUVEC shear stress experiments\",\n      \"journal\": \"Purinergic signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA, pharmacological, and mutation-based evidence; single lab with multiple approaches\",\n      \"pmids\": [\"25563726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Endothelial KLF2 mediates protection against cardiac maladaptive remodeling via a Klf2-Foxp1-TGFβ1 pathway; endothelial-specific KLF2 inhibition reverses simvastatin-mediated reduction of fibroblast proliferation and myofibroblast formation; KLF2 directly regulates TGFβ1 and Foxp1 in endothelial cells, and loss of Foxp1 phenocopies KLF2 inhibition.\",\n      \"method\": \"Endothelial-specific siRNA delivery via RGD-magnetic nanoparticles in vivo, pressure overload model, gene expression analysis, in vitro EC studies\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo endothelial-specific knockdown with defined cardiac phenotype, epistasis via Foxp1 inhibition, single lab\",\n      \"pmids\": [\"33408770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KLF2 directly promotes Vav1 transcription in adult DRG neurons; increased Vav1 then promotes axon regeneration by activating Rac1 GTPase; Klf2 is induced by retrograde Ca2+ signaling from injured axons, establishing a Klf2-Vav1-Rac1 axis in peripheral nerve regeneration.\",\n      \"method\": \"RNA-seq after sciatic nerve crush, ChIP for KLF2 at Vav1 promoter, siRNA/overexpression knockdown in DRG neurons, Vav1 KO functional rescue\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP, Rac1 GTPase activation assay, single lab with multiple methods\",\n      \"pmids\": [\"34147481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"KLF2 inhibits ferroptosis in clear cell renal cell carcinoma by transcriptionally repressing GPX4; KLF2 deficiency impairs GPX4 repression, promoting migration and invasion; reverting KLF2 expression in vivo decreases pulmonary metastases, and GPX4 overexpression reverses KLF2-mediated anti-metastatic effects.\",\n      \"method\": \"KLF2 overexpression/knockdown in vitro and in vivo, GPX4 expression analysis, ferroptosis assays, xenograft mouse model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional manipulation with GPX4 rescue experiment, in vivo validation, single lab\",\n      \"pmids\": [\"34520818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KLF2 directly binds the IRF4 promoter (demonstrated by dual luciferase reporter gene assay and ChIP) and upregulates IRF4 expression; IRF4 in turn binds the HDAC7 promoter to increase HDAC7 expression, forming a KLF2-IRF4-HDAC7 neuroprotective pathway in hypoxic-ischemic brain damage.\",\n      \"method\": \"Dual luciferase reporter gene assay, ChIP, adenoviral KLF2 overexpression, in vivo HIBD rat model, OGD neuron model\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding demonstrated by ChIP and reporter assay, in vivo and in vitro validation, single lab\",\n      \"pmids\": [\"35091544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IRF2BP2 regulates KLF2 expression; KLF2 overexpression in osteoclast precursors inhibits osteoclast differentiation by downregulating c-Fos, NFATc1, and TRAP, while KLF2 overexpression in osteoblasts enhances differentiation by upregulating Runx2, ALP, and BSP; IRF2BP2 effects on bone cells are reversed by KLF2 downregulation.\",\n      \"method\": \"Overexpression and siRNA knockdown in osteoclast precursor and osteoblast cell lines, differentiation marker assays, epistasis by KLF2 siRNA rescue\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by KLF2 knockdown reversal of IRF2BP2 effects, bidirectional manipulation, single lab\",\n      \"pmids\": [\"31186082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Restoring KLF2 expression in the carotid body of heart failure rabbits (via adenoviral transfection) reduces sympathetic nerve activity, arrhythmia incidence, and chemoreflex sensitivity; lentiviral KLF2 siRNA in the carotid body increases chemoreflex sensitivity and sympathetic activation, establishing KLF2 as a regulator of carotid body chemoreflex function.\",\n      \"method\": \"In vivo adenoviral KLF2 transfection and lentiviral siRNA knockdown in carotid body, measurement of ventilation, renal SNA, ECG, arrhythmia, breathing patterns\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional in vivo manipulation with defined physiological phenotypes, single lab\",\n      \"pmids\": [\"29023738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KLF2 regulates neutrophil NETosis pathway activated by chronic angiotensin II infusion; mechanistically, KLF2 controls neutrophil activation partly through crosstalk with HIF1 signaling; KLF2-dependent NETosis triggers sporadic thrombosis in small myocardial vessels leading to cardiac hypertrophy.\",\n      \"method\": \"Mouse model of Ang II-induced cardiac dysfunction, neutrophil-specific KLF2 manipulation, NET/thrombosis targeting, HIF1 signaling analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic model with defined mechanistic pathway (KLF2-NETosis-thrombosis), single lab with multiple pharmacological interventions\",\n      \"pmids\": [\"34793333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KLF2 regulates chemoreflex-related carotid body function by modulating BDNF/TrkB pathway in microglial cells under oxygen-glucose deprivation; KLF2 overexpression increases BDNF and TrkB levels and protects against OGD-induced apoptosis; these KLF2 effects are blocked by BDNF/TrkB inhibitor K252a, establishing KLF2 upstream of BDNF/TrkB signaling.\",\n      \"method\": \"Adenoviral KLF2 overexpression in BV2 cells, OGD model, K252a (BDNF/TrkB inhibitor) epistasis, cell viability/apoptosis assays\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single cell-line model, pathway epistasis by pharmacological inhibitor only\",\n      \"pmids\": [\"31821872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"KLF2 inhibits TGF-β/Smad signaling in hepatocellular carcinoma cells by inhibiting the transcriptional activity of Smad2/3 and Smad4, creating a negative feedback loop; stably expressed KLF2 attenuates TGF-β-induced MMP2 upregulation and cancer cell motility.\",\n      \"method\": \"Luciferase reporter assay for Smad transcriptional activity, stable KLF2 expression, wound-healing and transwell assays, MMP2 expression analysis\",\n      \"journal\": \"Acta biochimica et biophysica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transcriptional activity assay (luciferase reporter) for Smad inhibition, functional cell motility assays, single lab\",\n      \"pmids\": [\"32318691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KLF2 induces KLF2-mediated autophagy in dental pulp-derived stem cells (DPSCs) during osteoblast differentiation; ChIP analysis confirmed KLF2 and active epigenetic marks (H3K27Ac and H3K4me3) are upregulated in the ATG7 promoter region during OB differentiation; a metabolic shift from mitochondrial respiration to glycolysis occurs during OB differentiation.\",\n      \"method\": \"ChIP for KLF2 and histone marks at ATG7 promoter, Seahorse flux analysis, ROS measurements, gain/loss-of-function of KLF2 and autophagy genes (ATG7, BECN1)\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct KLF2 binding at ATG7 promoter by ChIP with histone modification marks, metabolic flux measurements, single lab\",\n      \"pmids\": [\"32777717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL3-mediated N6-methyladenosine (m6A) modification of KLF2 mRNA plays a crucial role in protecting pulmonary artery endothelial cells from EndMT; m6A modification stabilizes KLF2 mRNA; mutations in m6A sites of KLF2 mRNA compromise KLF2 expression and its protective effect; KLF2 modulates SM22 expression through direct binding to its promoter.\",\n      \"method\": \"RNA methylation quantification, m6A-RIP-qPCR, mRNA stability assay, m6A site mutation, dual-luciferase assay for KLF2 binding to SM22 promoter, endothelial-specific Mettl3 KO mice\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct mRNA modification and promoter binding demonstrated, in vivo KO validation, single lab with multiple methods\",\n      \"pmids\": [\"38741032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Simvastatin upregulates S1PR1 transcription via KLF2: simvastatin induces KLF2 recruitment to the S1PR1 promoter (demonstrated by ChIP); KLF2 silencing significantly attenuates simvastatin-induced S1PR1 promoter activity and augmented S1PR1 agonist-mediated barrier enhancement.\",\n      \"method\": \"ChIP for KLF2 at S1PR1 promoter, luciferase reporter assay, siRNA KLF2 knockdown, transendothelial electrical resistance assay, in vivo mouse lung microarray\",\n      \"journal\": \"Pulmonary circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP, functional rescue by KLF2 siRNA, single lab\",\n      \"pmids\": [\"28680571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"KLF2 is required to suppress the exhaustion-promoting transcription factor TOX and to enable TBET to drive effector differentiation during acute LCMV infection; KLF2 KO results in aberrant differentiation to exhausted-like CD8 T cells during acute infection, and KLF2 is necessary to maintain a polyfunctional tumor-specific progenitor state.\",\n      \"method\": \"In vivo CRISPR-Cas9-based perturbation sequencing (~40 TFs), KLF2 KO during LCMV infection, TOX and TBET expression analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo CRISPR-based genetic perturbation with defined exhaustion/effector phenotype and mechanistic TF (TOX, TBET) identification\",\n      \"pmids\": [\"39946463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In CAR T cells, KLF2 acts as a hub transcription factor in the effector gene network and enhances effector CD8+ T cell differentiation while preventing terminal exhaustion; FOXP1 (hub in stem-like network) and KLF2 (hub in effector network) reciprocally regulate checkpoints of stem-like to effector transition.\",\n      \"method\": \"Single-cell paired chromatin accessibility and transcriptome profiling (ATAC+RNA-seq) in CAR T cells, enhancer network analysis, FOXP1/KLF2 functional perturbations\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chromatin accessibility and transcriptome profiling with functional perturbation, single lab\",\n      \"pmids\": [\"38012417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KLF2 directly regulates osteoclastogenesis and osteoblast differentiation; IRF2BP2 overexpression suppresses osteoclast differentiation and enhances osteoblast differentiation through KLF2; effects are reversed by downregulating KLF2, establishing IRF2BP2-KLF2 as a regulatory axis in bone homeostasis.\",\n      \"method\": \"Overexpression and siRNA knockdown of IRF2BP2 and KLF2 in bone cells, epistasis rescue, differentiation marker assays\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by KLF2 siRNA reversal of IRF2BP2 effects, bidirectional manipulation, single lab\",\n      \"pmids\": [\"31186082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KLF2 interacts with FOXO4 and cooperates with FOXO4 to induce p21 expression and cellular senescence in pancreatic cancer cells; downregulation of either p21 or FOXO4 impairs KLF2-induced senescence.\",\n      \"method\": \"Co-immunoprecipitation (KLF2-FOXO4 interaction), KLF2 overexpression/knockdown, p21 and FOXO4 siRNA knockdown, senescence assays\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — physical interaction by Co-IP, functional epistasis via FOXO4/p21 knockdown, single lab\",\n      \"pmids\": [\"31866399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"KLF2 interacts with hexokinase 1 (HK1) and inhibits HK1-mediated glucose metabolism reprogramming, thereby suppressing endothelial-to-mesenchymal transition (EndMT); KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification through this KLF2/HK1 axis.\",\n      \"method\": \"Co-immunoprecipitation (KLF2-HK1 interaction), HK1 knockdown, KLF2 overexpression/knockdown, glycolysis measurements in HUVECs\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — physical interaction by Co-IP, functional knockdown with metabolic readouts, single lab\",\n      \"pmids\": [\"34363795\", \"33253911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KLF2 interacts with β-catenin and negatively regulates β-catenin/TCF signaling in pancreatic ductal adenocarcinoma cells, thereby inhibiting cell growth and migration.\",\n      \"method\": \"Co-immunoprecipitation (KLF2-β-catenin), overexpression in PDAC cells, TCF reporter assay, migration/growth assays\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"26449825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In zebrafish, klf2a and klf2b are required for Notch signaling activation in the endocardium and heart regeneration; klf2 gene expression is regulated by primary cilia-dependent mechanosensing of blood flow changes, placing klf2 downstream of primary cilia in a cilia-klf2-Notch axis.\",\n      \"method\": \"Zebrafish heart regeneration model, klf2a/klf2b morpholino knockdown, primary cilia mutants, Notch reporter assays\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in zebrafish with cilia and Notch pathway readouts, single lab\",\n      \"pmids\": [\"32249387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In zebrafish valvulogenesis, Erk5-Klf2-Wnt9a signaling (activated by shear stress) drives Wnt9a production, which induces ingression of endocardial cells into cardiac jelly to form abluminal cell populations; this mechanosensitive Klf2 pathway runs in parallel with Notch-Dll4 lateral inhibition to sculpt valve leaflets.\",\n      \"method\": \"Zebrafish valvulogenesis model, klf2 and wnt9a genetic/morpholino manipulations, Notch-Dll4 pathway epistasis, live imaging\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in zebrafish with live imaging, pathway placement by parallel manipulation, single lab\",\n      \"pmids\": [\"34610316\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KLF2 (LKLF) is a zinc-finger transcription factor that directly binds promoters (CACCC/Sp1-3 elements) to transcriptionally activate or repress target genes including eNOS, thrombomodulin, S1PR1, p21, GPX4, PFKFB3, AQP1, IRF4, Vav1, and Becn1; it is activated downstream of a PIEZO1/P2X4-Ca2+-CaMKII-MEKK3-MEK5-ERK5-MEF2 mechanosensory cascade in endothelial cells, and its expression is maintained epigenetically by KDM3A-mediated H3K9 demethylation and by METTL3-dependent m6A stabilization of its mRNA; in T cells, KLF2 programs quiescence by repressing c-Myc, drives effector differentiation while suppressing TOX-dependent exhaustion, and controls trafficking via S1PR1 and CD62L; in endothelium, it coordinately suppresses thrombosis, inflammation, glycolysis (via PFKFB3 repression), and EndMT, and is required with KLF4 for adult vascular integrity; loss-of-function mutations in its zinc-finger domains inactivate its ability to suppress NF-κB-driven signaling and underlie splenic marginal zone lymphoma pathogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KLF2 (LKLF) is a zinc-finger transcription factor that binds gene promoters to program quiescence, vascular integrity, and cell-fate decisions across hematopoietic, endothelial, and other lineages [#0, #7]. In the endothelium it serves as the central effector of mechanosensing: laminar shear stress, transduced through PIEZO1 and P2X4-dependent calcium signaling into a CaMKII-MEKK3-MEK5-ERK5 cascade, induces KLF2 transcription [#27, #28], and KLF2 in turn reprograms the endothelial transcriptome to enforce an antithrombotic, anti-inflammatory, and quiescent state \\u2014 directly inducing thrombomodulin and eNOS while restraining tissue factor and PAI-1 [#7], suppressing proinflammatory genes via ATF2 [#9], repressing the glycolytic regulator PFKFB3 to limit angiogenic sprouting [#12], and repressing the pro-migratory effector PAK1 [#20]. KLF2 and KLF4 act with substantial redundancy to maintain adult vascular integrity, and combined endothelial loss is acutely lethal [#19]; aberrant gain of MEKK3-KLF2/KLF4 signaling upon loss of the CCM complex drives cerebral cavernous malformation lesions [#16]. In lymphocytes KLF2 programs the quiescent single-positive T-cell state and maintains viability, in part by repressing c-Myc [#0, #3], controls trafficking through CD62L and the S1P receptor S1PR1 [#10, #15], restrains T follicular helper differentiation via S1PR1 and Blimp-1/Bcl-6 [#15], and is required to suppress the exhaustion factor TOX while enabling TBET-driven effector differentiation in CD8 T cells [#41, #42]. KLF2 acts as a tumor suppressor in multiple settings, including by repressing GPX4 to license ferroptosis [#31] and by antagonizing NF-\\u03baB signaling \\u2014 loss-of-function mutations in its zinc-finger domains that abolish this NF-\\u03baB suppression underlie splenic marginal zone lymphoma [#14]. KLF2 expression is itself maintained by KDM3A-mediated H3K9 demethylation [#17] and METTL3-dependent m6A stabilization of its mRNA [#39].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established KLF2's foundational physiological roles by showing it is genetically required both for T-cell quiescence/survival and for vascular wall stabilization during development.\",\n      \"evidence\": \"Knockout mice with in vivo T-cell phenotyping and vascular morphogenesis analysis by multiple imaging methods\",\n      \"pmids\": [\"9302292\", \"9367982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the transcriptional targets mediating quiescence or vessel stabilization\", \"Embryonic lethality limited analysis of adult vascular roles\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Extended the essential developmental requirement to erythropoiesis, showing the closely related EKLF cannot compensate for KLF2 loss.\",\n      \"evidence\": \"Knockout mouse with in vitro fetal liver erythroid colony assay\",\n      \"pmids\": [\"9859212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct erythroid target genes not defined in this study\", \"Mechanism of non-redundancy with EKLF unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolved how KLF2 enforces T-cell quiescence by showing it acts sufficiently and partly through repression of c-Myc.\",\n      \"evidence\": \"Gain-of-function in Jurkat cells with dominant-negative MadMyc mimicry and c-Myc rescue epistasis\",\n      \"pmids\": [\"11477405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other quiescence effectors beyond c-Myc not enumerated\", \"Direct vs. indirect repression of c-Myc not distinguished\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined KLF2 as a direct promoter-binding repressor by showing it inhibits PPAR\\u03b32 transcription to restrain adipogenesis.\",\n      \"evidence\": \"Reporter assays, promoter mutational analysis, and EMSA in preadipocytes\",\n      \"pmids\": [\"12426306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance to adipose biology not tested\", \"Did not address whether repression is direct binding versus cofactor-mediated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placed KLF2 in a signaling pathway by showing TRAF2/p38 controls its expression independent of NF-\\u03baB, with anti-apoptotic consequences.\",\n      \"evidence\": \"Microarray comparison of TRAF2-/- cells with ectopic-expression rescue and pathway inhibitors\",\n      \"pmids\": [\"12897154\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional control of KLF2 by p38 not demonstrated\", \"Anti-apoptotic targets downstream of KLF2 not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified the cis-element basis of KLF2 antiproliferative activity, mapping induction of p21 to the Sp1-3 site and requiring both activation and inhibitory domains.\",\n      \"evidence\": \"Tetracycline-inducible expression with luciferase reporter and promoter mutational analysis in Jurkat cells\",\n      \"pmids\": [\"15361832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous p21 regulation by KLF2 in primary cells not tested\", \"Domain contributions to other targets not generalized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established KLF2 as the shear-stress-responsive master regulator of endothelial antithrombotic and vascular-tone programs.\",\n      \"evidence\": \"Adenoviral overexpression and siRNA knockdown with clotting assays, plus in vivo carotid collar shear model with laser microdissection\",\n      \"pmids\": [\"15718498\", \"16049344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream mechanosensors transducing shear to KLF2 not yet defined\", \"Direct promoter occupancy at thrombomodulin/eNOS not shown in these studies\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Provided a mechanism for KLF2 atheroprotection by showing it suppresses proinflammatory genes via inhibition of ATF2 nuclear binding.\",\n      \"evidence\": \"Genome-wide profiling, ATF2 nuclear binding assay, and siRNA in HUVEC shear experiments\",\n      \"pmids\": [\"17244683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical interaction between KLF2 and ATF2 not established\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated direct chromatin occupancy of KLF2 at globin regulatory elements, establishing its role in embryonic/fetal globin gene expression.\",\n      \"evidence\": \"ChIP in primary embryonic blood cells with conditional KO and transgenic human globin locus models\",\n      \"pmids\": [\"21610079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional separation of KLF1 versus KLF2 contributions incompletely resolved\", \"Cofactors recruited to globin loci not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined KLF2's role in B-cell homeostasis and trafficking via control of CD62L and \\u03b27-integrin, revealing lineage-specific differences from T cells.\",\n      \"evidence\": \"B-cell-specific conditional KO with flow cytometry and gene expression analysis\",\n      \"pmids\": [\"21187410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why S1PR1 is minimally affected in B cells unlike T cells unexplained\", \"Direct targets controlling B1/marginal-zone partitioning not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked KLF2 to endothelial metabolism, showing it represses PFKFB3 to suppress glycolysis and angiogenic sprouting under laminar flow.\",\n      \"evidence\": \"Seahorse flux, reporter assays, RNA-seq, and endothelial-specific KO with PFKFB3 rescue\",\n      \"pmids\": [\"25359860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether metabolic and inflammatory programs are independently regulated not resolved\", \"Direct PFKFB3 promoter occupancy by KLF2 not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected KLF2 to disease by defining IKK\\u03b2-regulated, CCM-regulated, and mutation-driven control of KLF2 activity in coagulation and lymphoma.\",\n      \"evidence\": \"ChIP and KLF2 knockdown for IKK\\u03b2-thrombomodulin axis; zebrafish CCM epistasis; whole-exome sequencing with NF-\\u03baB reporter assays of mutant KLF2\",\n      \"pmids\": [\"25039491\", \"25625207\", \"25428260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which zinc-finger mutations specifically lose NF-\\u03baB suppression not structurally defined\", \"Direct NF-\\u03baB target promoters bound by KLF2 not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved the mechanosensory input to KLF2, showing PIEZO1 and P2X4 transduce shear into calcium/CaMKII-MEKK3-ERK5 signaling that drives KLF2 transcription.\",\n      \"evidence\": \"Endothelial-specific Piezo1 KO, P2X4 siRNA/antagonist and loss-of-function variant, CaMKII-MEKK3 interaction assays in shear experiments\",\n      \"pmids\": [\"35883633\", \"25563726\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of PIEZO1 versus P2X4 not integrated\", \"Single-lab signaling reconstruction\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established KLF2 as a checkpoint of T-cell differentiation and trafficking, controlling S1PR1, Blimp-1/Bcl-6, and Tfh versus Th1 fate.\",\n      \"evidence\": \"Inducible CD4 T-cell deletion and overexpression with in vivo Tfh quantification and gene expression analysis\",\n      \"pmids\": [\"25692701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect induction of Blimp-1, T-bet, GATA3 not all distinguished\", \"Promoter occupancy not shown for all targets\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined the MEKK3-KLF2/4 gain-of-signaling mechanism underlying CCM lesion formation and confirmed KLF2's homeostatic role in NK-cell survival.\",\n      \"evidence\": \"Neonatal CCM mouse model with endothelial-specific Mekk3/Klf2/Klf4 KO and human lesion staining; NK-cell KO with proliferation/homing assays\",\n      \"pmids\": [\"27027284\", \"27114551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Rho-activation link between KLF2 and lesion morphology mechanistically incomplete\", \"NK homing-receptor targets of KLF2 not all defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified the epigenetic and autoregulatory circuitry maintaining KLF2, via KDM3A-mediated H3K9 demethylation and a reciprocal KLF2-IRF4 loop in myeloma.\",\n      \"evidence\": \"siRNA of KDM3A/KLF2/IRF4, H3K9 ChIP, and in vitro/in vivo myeloma models\",\n      \"pmids\": [\"26728187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether KDM3A directly targets the KLF2 locus versus indirectly not fully resolved\", \"Generality of KLF2-IRF4 loop beyond myeloma unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated that KLF2 and KLF4 together control adult vascular integrity with dosage redundancy, with combined loss being acutely lethal.\",\n      \"evidence\": \"Inducible endothelial-specific Klf2/Klf4 double KO with transcriptome and coagulation analysis and gene-dosage testing\",\n      \"pmids\": [\"28239661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Division of labor between KLF2 and KLF4 at individual targets not resolved\", \"Which transcriptome subset is the lethal driver not pinpointed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Expanded KLF2 mechanism into migration, cardiac remodeling, and pharmacologic induction pathways linking statins, autophagy, and S1PR1.\",\n      \"evidence\": \"Erk5/MEK5 and PAK1 rescue migration assays; endothelial-specific Klf2 manipulation in cardiac remodeling; statin-Rac1-Rab7-autophagy and S1PR1 ChIP studies\",\n      \"pmids\": [\"25388666\", \"33408770\", \"27545498\", \"28680571\", \"27756792\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"These axes derive from individual single-lab studies\", \"Integration of autophagy feedback with transcriptional output unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended KLF2 function to bone, senescence, and protein-interaction mechanisms, including cooperation with FOXO4 and physical interaction with Runx2.\",\n      \"evidence\": \"Co-IP of KLF2-FOXO4 and KLF2-Runx2, IRF2BP2-KLF2 epistasis in bone cells, and differentiation/senescence assays\",\n      \"pmids\": [\"31866399\", \"30429507\", \"31186082\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physical interactions rest on single Co-IPs without reciprocal structural validation\", \"In vivo bone phenotypes of KLF2 not established here\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established KLF2 as a tumor suppressor and regenerative regulator acting through GPX4-dependent ferroptosis, HK1-dependent metabolism, Vav1-Rac1 axon regrowth, and cilia-Notch cardiac regeneration.\",\n      \"evidence\": \"KLF2 over/knockdown with GPX4 and HK1 rescue, DRG ChIP/Rac1 assays, and zebrafish cilia/Notch and valvulogenesis epistasis\",\n      \"pmids\": [\"34520818\", \"34363795\", \"34147481\", \"32249387\", \"34610316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each axis is single-lab and context-specific\", \"Whether these reflect a shared KLF2 transcriptional logic is unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified post-transcriptional control of KLF2 by METTL3-dependent m6A stabilization protecting against EndMT, and CRISPR-defined KLF2 as an effector hub suppressing CD8 T-cell exhaustion.\",\n      \"evidence\": \"m6A-RIP, mRNA stability, m6A-site mutation and endothelial Mettl3 KO; in vivo CRISPR perturbation screen with TOX/TBET analysis and CAR-T chromatin/transcriptome profiling\",\n      \"pmids\": [\"38741032\", \"39946463\", \"38012417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between m6A stabilization and KDM3A epigenetic control not integrated\", \"Direct KLF2 targets enforcing the anti-exhaustion program not fully mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How KLF2 selects between transcriptional activation and repression at individual targets, and how its many context-specific axes (vascular, immune, metabolic, regenerative) reflect a unified set of direct genomic targets, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genome-wide KLF2 occupancy map integrating cell types reported\", \"Cofactor switching between activation and repression not defined\", \"Division of labor with KLF4 at the locus level unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 6, 7, 11, 12, 15, 30, 31, 32, 39]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 11, 21, 22, 30, 40]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 11, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 6, 7, 11, 12, 30, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 27, 28, 37]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 10, 15, 18, 41, 42]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [7, 21, 19, 35]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [12, 45]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 16, 47, 48]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KLF4\", \"Runx2\", \"FOXO4\", \"HK1\", \"MEKK3\", \"IRF4\", \"ATF2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}